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INTRODUCTION 
5-HT (5-hydroxytryptamine, serotonin) has a widespread occurrence in 
numerous species of plants and animals. It is present for example in 
several vegetables and edible fruits, in the urticant fluid of the 
stinging nettle as well as in the intestine, blood platelets and nervous 
system of all classes of vertebrates. 
Its occurrence in the central nervous system (CNS) of both vertebrates 
and invertebrates has attracted particular attention. In the CNS the 
transmission of impulses from one nerve fibre to another is accomplished 
by the action of chemical mediators, called neurotransmitters. The 
junction between two nerve fibres is called synapse. At the arrival of 
an action-potential the presynaptically stored transmitter is released 
and subsequently causes the depolarization of the postsynaptic fibre as 
consequence of the interaction with a specific receptor, which is a 
molecular system incorporated in the post-synaptic membrane. 5-HT came 
to be regarded as a possible neurotransmitter. However, direct evidence 
for its neuronal localization was not presented until 1965 when Dahlstrom 
and Fuxe actually demonstrated its presence within the perikarya of the 
brain stem raphe nuclei and its projections in discrete regions of the 
fore-brain. 
The major portion of the 5-HT in the body of mammals is however found 
in the intestines where it is primarily located extraneuronally in the 
Entero-Chromaffin (E.C.)-system. The rat and mouse are exceptional in 
that quite a considerable portion is also found to be stored in mast 
cells. 
The 5-HT of the E.C.-system is probably synthetized within the cells. 
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The amine is stored in the cell granules which are also believed to 
store polypeptide hormones like secretin, glucagon etc. Mast cell 5-HT 
arises both from de novo synthesis from tryptophan and uptake of the 
amine itself. 
An enormous amount of information is now available about the distribution 
and effect of 5-HT. Investigation of the mechanism of action may provide 
information about its physiological role and the functional importance 
of its rather peculiar distribution. Its effects on mammalian smooth 
muscle of the alimentary tract have been described in some detail. 5-HT 
stimulates the intestines of several species including man. Its effect 
is quantitatively different according to the part of the intestine 
observed and to the species considered. The precursor of 5-HT, 5-hydroxy-
tryptophan also increases intestinal motility which can be prevented by 
a number of anti-5-HT drugs. 
The fact that 5-HT exerts a characteristic effect on smooth muscle is 
taken to indicate that the muscle possesses the receptors with which 5-HT 
can interact. Information about these receptors has been derived mostly 
fr~n in vitro experiments with freshly isolated preparations of smooth 
muscle. From cross-tachyphylaxis experiments on the guinea-pig ileum 
Gaddum (1953) concluded that the same type of receptors were involved in 
the mediation of the effects of 5-HT and tryptamine. The results obtained 
from quantitative studies of antagonists for 5-HT and tryptamine, led 
Gaddum and Picarelli {1957) to propose the existence of actually two 
types of tryptamine receptors in the guinea-pig ileum, one of which being 
blocked by morphine was accordingly labelled as theM-receptor. The site 
which was inactivated by dibenzyline (phenoxybenzamine) was denoted as 
the D-receptor. The M-tryptamine receptor is sited in the intramural 
parasympathetic ganglion cell (Brownlee and Johnson, 1963). The 
D-tryptamine receptors are localized within the membrane of smooth muscle 
cells. 
The sensitivity of different smooth muscles to 5-HT varies greatly. A 
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preparation very sensitive to 5-HT and easy in operation appeared to be 
the fundus strip preparation of the rat stomach (Vane, 1957}. Moreover 
the preparation was demonstrated to obtain solely the D-type of 
tryptamine receptors (Offermeier and Ariens, 1966). Besides being 
sensitive to 5-HT the preparation is moderately sensitive to prosta-
glandins and ACh and is rather insensitive to histamine, dopamine and 
various polypeptides like angiotensin and bradykinin. Relaxation of the 
organ is produced by a- and S-adrenoceptor agonists, though in the 
literature a "!so a-adrenoceptors with excitatory properties are described 
to be present in this preparation (Ogle and Wong, 1971). 
Because of the rather selective sensitivity of the fundus strip to 5-HT 
an explicit system is provided for drugs to be tested for antagonistic 
act.ivi ty towards the response of 5-HT mediated by D-tryptamine receptors. 
However, in the literature data were presented to indicate that other 
than the classical D-tryptamine receptors might be involved in the 
response of the rat fundus preparation to tryptamine (Winter and 
Gessner, 1968). Such an aberant type of tryptamine receptor seems also 
to be involved in the constrictor response of the external carotid 
vesses of dogs to 5-HT and ergotamine (Saxena and de Vlaam-Schluter, 
1974) and the anti-5-HT drug mianserin (Saxena et al. 1971). Moreover 
it has been demonstrated that 5-HT as well as tryptamine increased the 
release of prostaglandins (see ref. Manuscr. II). All these observations 
might be derogatory to the rather unique position of the rat stomach 
fundus preparation as a test-system for anti-5-HT activity. 
Therefore the purpose of this study was 
to find out whether the same types of receptors were involved 
in the responses to 5-HT and tryptamine. 
to compare the effects of ergotamine and mianserin on the 
fundus preparation with those described for the external 
carotid vessels of the dog. 
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A.L FRANKHUYZEN and LL. BONTA, Effect of mianserin, a potent anti-serotonin agent, in the isolated rat 
stomach fundus preparation, European J. PharmacaL 25 (1974) 40-50. 
The influence of mianserin and cyproheptadine on the responses of the rat stomach fundus in vitro to Ach 
(acetykhotine}, 5-HT (se;-otonin) and tryptamine in the presence of the o:-ad.renolytic, piperoxan, were compared. 
Cyproheptadine and mianserin competitively antagonized the Ach~induced contractions, but cyproheptadine was 
more effective. Mianserin, a recognized antagonist of 5~HT on rat uterus and on bronchospasm of the guinea pig, did 
not affect 5-HT- and tryptamine~induced contractions of the isolated rat stomach fundus in concentrations up to 
10·-6 M, while cyproheptadine proved highly effective. Higher doses of mianserin contracted the organ. A closed 
piperazine ring seems to be essential for such action. Although no anti-5-HT action could be found with mianserin 
on the rat fundus, it protected S~HT-induced contractions against inhibition by phenoxybenzamine, cyproheptadine 
or methysergide. The a~adrenolytic piperoxan was more effective in protecting the response to 5~HT than to Ach 
against inhibition by phenoxybenzamine. It is concluded that differences might exist between D-tryptamine recep-
tors in different organs and that the receptor protection by mianserin and piperoxan towards the 5~HT-induced 
contractions may be related to an ability to interact at Ca 2 +~binding sites of the smooth muscle cell membrane. 
However, the possibility that piperoxan might in some way interfere with an inhibitory action of mianserin towards 
tryptamine receptors is not ruled out. Although both the responses to 5~HT and tryptamine are affected by 
cyproheptadine, the S~HT-induced contractions were more susceptible to inhibition by cyproheptadine than those 
of tryptamine. This possibly indicated a subsidiary action of tryptamine on other than the D-tryptamine receptors. 
Anti-tryptamine 
Anti~S~HT 
l. Introduction 
D-Tryptamine receptors 
Rat fundus strip 
Mianserin, 2-methyl-l ,2,3,4,10,14b-hexahydro-
2H-pyrazino/l ,2-f/morphanthridine · HCl (Van der 
Burget al., 1970) was shown to be a potent antagonist 
* A preliminary report of some of this work has appeared in 
Arch. Intern. Pharmacodyn. Therap. 197 (1972) 378. 
**This paper comprises part of a Doctor's thesis in Pharma-
cology to be submitted by A.L.F. at the Erasmus Univer-
sity Rotterdam. 
Mianserin Cyproheptadine 
of both 5-HT and histamine in a number of in vivo and 
in vitro pharmacological preparations. Structurally re~ 
lated to cyproheptadine (fig. 1 ), its potency was com-
parable to the latter in antagonizing 5-HT-induced 
contractions of the rat uterus, capillary permeability 
increases, bronchoconstriction and rat paw oedema 
(Vargaftig et a!., 1971). It was somewhat less active 
than cyproheptadine against histamine-induced con~ 
tractions of the isolated guinea~pig ileum ~nd in the 
aerosol test, without having cholinolytic activity, 
whereas cyproheptadine showed anti~muscarinic ac~ 
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Fig. 1. Structure formula of cyproheptadine and mianserin 
(Vander Burget al., 1970, by permission). 
tivity. Mianserin was also shown to exhibit a-adreno-
lytic activity whereas cyproheptadine was devoid of it 
(Saxena eta!., 1971). 
We intended to investigate whether the antagonism 
by mianserin towards 5-HT was of the competitive or 
of the non-competitive type. For this purpose the 
isolated rat stomach fundus preparation was chosen, 
because it is more suitable than the rat uterus (Vane, 
1957). On the basis of their antagonism by phenoxy-
benzamine and morphine respectively the 5-HT recep-
tors are classified by Gaddum and Picarelli (1957) as 
belonging to the D- or M-type. Although the rat 
uterus as well as the rat stomach fundus both are 
believed to contain solely D-tryptamine receptors 
(Offermeier and Ariens, 1966), the cumulative dose-
response technique is more appropriate to the rat 
stomach fundus. 
Van der Burget a!. (1970) postulated that, apart 
from rigidity, an intersection angle of about 120° be-
tween the planes formed by the two aromatic nuclei 
of mianserin and also those of cyproheptadine is a 
st~uctural requirement for high anti-serotonin activi-
ty. In order to test whether this also holds for the rat 
fundus preparation, both compounds were compared 
with respect to their influence on the response to 
5-HT. 
We included tryptamine in the experiments to in-
vestigate whether differences existed with respect to 
5-HT, possibly indicating an action of tryptamine on 
other than D-tryptamine receptors. For this, sugges-
tions can be found in literature (Barlow and Khan, 
1959a,b; Barlow, 1961, Winter and Gessner, 1968). 
2. Materials and methods 
2.1. Experimental preparation 
Male albino Wistar rats weighing 200-300 g were 
killed by decapitation. The stomach was dissected out 
and strips cut according to the method described by 
Vane (1957). The strips were set up in an organ bath 
maintained at 37°C containing Tyrode solution and 
bubbled with a gas mixture containing 95% 0 2 -5% 
C02 • The composition of the Tyrode solution was 
(mM): NaCll36.8; KC12.7; CaCI, 1.8; MgCl 2 1.6; 
NaH2 P02 0.4; NaHC03 11.9; and glucose 5.6. Ex-
cept in the receptor-protection experiments, piper-
oxan (10-5 M) was added to the Tyrode solution to 
exclude an inhibitory action of 5-HT on a:-adrenocep-
tors as described by Offermeier and Ariens (1966). 
One end of the fundus strip was attached to the lever 
of a Harvard heart/smooth muscle transducer loaded 
with 1.0 g weight. The contractions were recorded 
with a Harvard electronic recording module 350. Be-
fore starting the experiments the fundus strips were 
allowed to equilibrate for 60 min during which the 
bathing fluid was changed every 15 min. 
2.2. Evaluation of antagonism 
pA2 and pD2 ' values were calculated according to 
Ariens et a!. (1956) and Van Rossum and Van den 
Brink (1963); pA2 values indicate the affinity of the 
competitive antagonist to the receptor and is denoted 
as the negative logarithm of the molar concentration 
of the antagonist which causes an elevation of the 
concentration of the agonist with a factor 2 in order 
to obtain the same response. pD2' values indicate the 
affinity of the non -competitive antagonist to the re-
ceptor and is denoted as the negative logarithm of the 
molar concentration of the antagonist which causes a 
50% reduction of the maximal effect of the agonist. 
2.3. Receptor-protection experiments 
The receptor-protection experiments were per· 
formed according to the method described by Furch-
gott (19 54) as modified by Winter and Gessner 
(1968). For one single receptor-protection experi-
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Fig. 2a. Schedule of the blocking experiments. The upper 
row in both figures (2a and 2b) represents the blank. The 
second row represents the actual blocking or receptor-protec-
tion experiment. The letter at the top of each contraction is 
referred to in the formulae for the calculation of the % in-
hibition of control or protected strips. Downward arrows in-
dicate washing of the preparation. For the administration of 
drugs a 5 min time cycle was used (see under Materials and 
methods 2.3.). Ach =acetylcholine (10-4M), 5-HT (10-s M), 
Dibenz. "' phenoxybenzamine (10-4M), Mians. = mianserin 
oo""MJ. 
ment 4 fundus strips were used at the same time: 2 
strips for the blocking experiment, the other 2 strips 
for the protection experiment. 
2.3.1. Blocking experiment (fig. 2a) 
2 fundus strips, A and B, were used at the same 
time; strip A served as a control, while strip B was 
exposed to the antagonist. At first the response of 
both strips to Ach (10-4 M) and 5-HT (10-5 M) was 
recorded. The contraction height is denoted as A1 for 
strip A and B1 for strip B. Thereafter, strip B was 
exposed for 5 min to the antagonist, after which time 
the response to Ach and 5-HT of both preparations 
was again recorded. The contraction height is denoted 
A2 for strip A and B2 for strip B. The response of 
strip B expected in the absence of the antagonist is 
given by: 
strip C 'I~ f c2 ! 
I I I 
Ach 5-HT mians. Ach 5-HT 
j 
strip 
"i 
o, { ( "'J ~ 
I 
Ach 5-HT mians. dibenz. Ach 5-HT 
Fig. 2b. Schedule of the receptor-protection experiments. 
For further information see fig. 2a. 
in which the letters stand for the contraction height 
of Ach or 5-HT in mm. The percentage inhibition of 
the response of strip B in the presence of the antago-
nist is then given by: 
2.3.2. Protection experiments (fig. 2b) 
2 strips, C and D, were used at the same time; strip 
C served as a control, strip D was used for the protec-
tion experiment. The procedure was the same as in 
the blocking experiments. The contraction heights of 
strip C (= C,) and of strip D (= D,) were recorded 
after administration of Ach (l o-• M) and 5-HT 
(10-5 M). Both strips were exposed to the protecting 
drug. The antagonist was administered after 5 min to 
strip D and left in contact with the tissue for another 
5 min, thereafter the response to Ach and that to 
5-HT was recorded denoting the contraction heights 
of strip Cas C2 and of strip D as D2 . 
The response expected in the protection experi-
ment is given by: 
The percentage inhibition of the protected strip D of 
the response to Achor 5-HT is given by: 
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and the percentage protection by: 
%Prot= 100 (I - %1pwtf%Icontcl 
2.4. Drugs 
The following drugs were used: acetylcholine 
(Fluka A.G.), serotonin creatinine sulphate (Fluka 
A.G.), tryptamine (Fluka A.G.), cyproheptadine 
(Periactin, Merck Sharp and Dohme), methysergide 
(Deseril, Sandoz), piperoxan (May and Baker), phen-
oxybenzamine (Dibenzyline, Merck Sharp and 
Dohme), hyoscine (Scopolamine, Brocades), mor-
phine, propranolol (Inderal, Sandoz), chlorpromazine 
(Largactil, S.P.E.C.I.A.), sotalol (Mead Johnson), 
Dexamphetamine, 6-methylaminomethyl-5 ,6-dihy-
dromorphanthridine (Organon), mianserin (Organon). 
The solutions of the salts of the drugs were prepared 
freshly on the day of the experiment. Drug solutions 
were added to the 5 rnl organ bath in a volume of 
0.1 mi. All concentrations mentioned refer to the 
final concentration of the drug in the organ bath and 
are expressed in terms of molarity. 
3. Results 
3.1. Influence of cyproheptadine and mianserin on 
the response to acetylcholine, 5-HT and tryptamine 
The influence of different concentrations of 
cyproheptadine on the log dose-response curves of 
Ach, 5-HT and tryptamine was investigated (fig. 3a, 
b, c). Cyproheptadine provided powerful antagonism 
against contractions induced by Ach, 5-HT as well as 
by tryptamine. Administration of cyproheptadine re-
sulted in a parallel shift to the right of the log dose-
response curves indicating a competitive type of an-
tagonism. Only in the case of 5-HT was this shift 
accompanied by a lowering of the maximal height of 
Fig. 3a, b, c. Influence of cyproheptadine on the response of 
rat stomach fundus strips to Ach (fig. 3a), 5-HT {fig. 3b) and 
tryptamine (fig. 3c) in the presence of piperoxan (10-5 M). 
•-•, 0 M cyproheptadine; •-•, 10-7 M; 6-6, 3 X 10-7 M; 
A-.&, w-6 M; 0-0, 10-s M. The vertical bars in the figures 
indicate the SEM. out of 10 experiments. 
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the curve, possibly indicating a non-competitive char-
acter. This implies that cyproheptadine exhibited a 
dualism in its antagonism of 5-HT. 
Compared with cyproheptadine, mianserin exerted 
only a weak competitive type of antagonism towards 
Ach (fig. 4a). ln contrast to cyproheptadine, mian-
serin did not antagonize the response of the rat 
fundus to 5-HT and tryptamine up to a concentration 
of J0- 6 M (fig. 4b,c). Administration of still higher 
doses of mianserin resulted in a contraction of the 
organ. This is shown in all 3 figures by the elevated 
cyproheptadine. From the same table it can be seen, 
that the tryptamine-induced contractions are less af-
fected by cyproheptadine than those of 5-HT. The 
pA2 value of cyproheptadine towards tryptamine is 
significantly lower than towards 5-HT (p < 0.001). 
3.2. Contraction of the rat fundus strip by mianserin 
The contraction induced by mianserin had a slow 
onset and reached its maximal height after about 
2-5 min. After washing the preparation the tonus of 
the organ stayed elevated and even after 1 hr the 
preparation had not returned to its original base line. 
In fig. 5 log dose-response curves are shown of 
BaC)z, Ach, 5-HT, tryptamine and mianserin. In the 
case of mianserin the single dose-response technique 
was used instead of the cumulative technique. Be-
cause of the relatively long time needed by mianserin 
to obtain its maximal contraction height, possible 
processes such as desensitization or auto-inhibition 
might develop (Guirnaraes, 1972). The pD2 value of 
the mianserin-induced contraction was 4.65 ± 0.15. 
Its maximal contraction height relative to BaC12 was 
71 ± 3%, which is lower than for Ach (91 ± 2%), 
5-HT (79 ± 2%) and tryptamine (81 ± 3%). The piper-
azine ring seemed to be a structural requirement for 
the spasmogenic action of mianserin. The open di-
amine analogue of mianserin (table 2), in a concentra-
tion of 10-4 M, did not contract the organ. 
Fig. 4a, b, c. Influence of mianserin on the response of rat 
stomach fundus strips to Ach (fig.4a), 5-HT (fig. 4b) and 
tryptamine (fig. 4c). •-•, 0 M mianserin; •-•, 10-6M; 6-6, 
10-s M; .t..-..t., 2 X 10-s M; o-o, 3 X 10-5 M; o-o, 10-4M. 
Log dose-response curves of Ach, 5-HT and tryptamine were 
recorded in the presence of piperoxan (10-5 M). The pre-
incubation time of the antagonists was 1 hr. The values (ex-
pressed in % of maximal contraction) of each curve are the 
mean out of 10 experiments ± S .E.M. 
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Table 1 
pA2 and pD2 ' values of cyproheptadine and mianserin to~ 
wards the response of the isolated rat stomach fundus prepa-
ration to Ach, 5-HT and tryptamine. These values(± S.E.M.) 
are the mean of the pA2 and pD2 'values obtained from the 
experiments in which different concentrations of the antago-
nists were used. 
\"""-• Antago- Cyproheptadine Mianserin ~nist 
Agoni~~ pAZ p02 pAZ p02 
Ach 8,03 ~ 0,10 - 6,05 ~ 0,35 -
~5-HT 7,50 ~ 0,10 5,43 ~ 0,09 no effect 
Tryptamine 6,87 ~ 0, 11 - no effect 
3.3. Inhibition of mianserin-induced contraction 
I 
%of mcx. 
contraction 
45 
-log cone. 
In an attempt to analyse the contraction of the rat 
fundus strip to mianserin, the following antagonists 
were used: atropine, scopolamine, morphine, methy-
sergide, cyproheptadine, propranolol, phenoxybenz-
amine, and chlorpromazine. All antagonists were used 
in concentrations which completely blocked re-
Fig. 5. Log dose-response curves of 5-HT (•-•), acetylcho-
line (•-•), tryptamine (""-""), mianserin (""-•) and BaCI2 
(o-o) on the isolated rat stomach fundus preparation in the 
presence of piperoxan 10· 5M. The values (expressed in% of 
maximal contraction relative to that of BaCI2) of each curve 
are the mean out of 10 experiments± S.E.M. 
Table 2 
%Protection of the response of rat fundus strips to Ach (10-4M) and 5-HT (10-s M) by mianserin, its open diamine analogue and 
piperoxan against inhibition by phenoxybenzamine (Dibenzyline) (10- 4M), cyproheptadine (10-6M) and methysergide (1o-6M). 
Compound tested for 
Agonist Antagonist receptor protection concentr. % Protection 
5-HT Dibenzyline 
Aoh id. 
5-HT Cyproheptadine** 
5-HT Methysergide * * 
orp 10-4M 92+ 7 113)' 10-4M 86 + 4 1131 
\_N 10-6M 110 + 10 110) 
mionserin 'cH 
10-6M 3 90 + 10 110) 
\ ~ N H 
5-HT Dibenzyl ine 
Aoh id. 
N 10-4M 31 + 8 I 71 H 'cH 3 
10-4M 6- methyl ominomethyl-5,6- 1 + I 71 
dihydromorphonthridine *** 
5-HT id. piperoxan 10-SM 49 + 6 113) 
Aoh id. piperoxan 10-SM 20 + 5 113) 
* Mean values are given± S.E.M. The number of experiments is given between parentheses. 
**The procedure was slightly changed in the experiments using cyproheptadine and methysergide. The contractions were 
recorded in the presence of both protecting and blocking drug. 
* ** No spasmogenic action of the open diamine analogue of mianserin. 
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sponses to acetylcholine, 5-hydroxytryptamine and"· 
and ~*adrenoceptor agonists. In these experiments 
only one concentration of rnianserin was used 
(3 X 10-5 M), which gave approximately 50% of the 
maximal contraction height of the mianserin log 
dose-response curve. Only chlorpromazine (10-4 M) 
was able to inhibit the mianserin-induced contraction. 
However, the same concentration of chlorpromazine 
also inhibited the response of the rat fundus to 
BaCh, probably indicating an unspecific spasmolytic 
action of chlorpromazine. When incubating the tissue 
with 5-HT, dexamphetamine or tryptamine for I hr, 
cross-tachyphylaxis developed between 5-HT, dexam-
phetamine and tryptamine. However, normal re-
sponses to mianserin could still be obtained. 
3.4. Receptor-protection experiments 
Another means of investigating whether or not 
mianserin shows affinity towards tryptamine recep-
tors is to determine whether mianserin is able to pre-
vent inhibition of the response to 5-HT by a competi-
tive antagonist. The first antagonist used was the 
alkylating agent, phenoxybenzamine. Administration 
of mianserin (10- 4M) 5 min prior to phenoxyben-
zamine (10- 4 M) protected both the response to 5-HT 
and to Ach from inhibition by phenoxybenzamine 
(table 2). A representative record of the receptor-pro-
tection experiments with phenoxybenzamine is shown 
in fig. 6a. 
Phenoxybenzamine is a recognized a-adrenolytic 
agent. Responses to 5-HT which are mediated by <>· 
adrenoceptors are known from the literature (Innes, 
1962) and also for the isolated rat fundus preparation 
(Abramets, 1969). Saxena et al. (1971) showed in 
their experiments, in which they investigated the in-
fluence of mianserin on vascular responses, that mian-
serin exerted a-adrenolytic activity. Because of their 
common affmity towards a-adrenoceptors, 2 other 
serotonin antagonists were used in these receptor-
protection experiments, methysergide and cyprohep-
tadine. For these 2 antagonists, no interaction with 
a-adrenoceptors has been described. Because both an-
tagonists are slightly reversible, the procedure for the 
receptor-protection experiments was slightly changed. 
The responses to 5-HT were recorded in the presence 
of both mianserin and the respective antagonist. Mian-
serin, in a concentration of 10-6 M, prevented also 
the inhibition of both cyproheptadine and methyser-
gide of the response to 5-HT. Representative records 
of the receptor-protection experiments with cypro-
heptadine and methysergide are shown in fig. 6b, c. 
Using the open diamine analogue of mianserin it 
was possible to investigate the influence of the pipera-
zine-ring structure on both the spasmogenic action 
and the receptor-protective capacity of rnianserin. 
Administration of the open diamine analogue did not 
result in a contraction of the organ. The percentage 
protection against inhibition by phenoxybenzamine of 
both 5-HT and Ach was drastically diminished. No pro-
tection was found anymore with respect to the re-
sponse to Ach. The percentage protection towards 5-
HT was only about 1/3 of the protection exerted by 
mianserin (table 2). 
Piperoxan was also included in the receptor-
protection experiments. It was observed, that the in-
hibition of the response to 5-HT by phenoxybenza-
mine was much less than of the response to Ach when 
piperoxan was present in the Tyrode solution. From 
table 2 it can be seen, that piperoxan in a concentra-
tion of 10-5 M showed receptor-protective capacity 
towards 5-HT as well as towards Ach. The percentage 
protection by piperoxan towards the 5-HT-induced 
contractions was significantly (p < 0.001) higher than 
towards Ach. 
4. Discussion 
The potency of mianserin in antagonizing the re-
sponse to 5-HT in a variety of in vitro and in vivo 
pharmacological preparations was comparable with 
cyproheptadine (Van der Burget al., 1970; Vargaftig 
et a!., 1971 ). On the rat stomach fundus preparation, 
in vitro cyproheptadine provides a potent competitive 
antagonism towards 5-HT and tryptamine- as well as 
towards Ach-induced contraction. Compared with 
cyproheptadine (pA2 = 8.03 ± 0.10), mianserin pos-
esses only weak competitive cholinolytic properties 
(pA2 = 6.05 ± 0.35). In contrast mianserin did not in-
hibit the responses to 5-HT and tryptamine in concen-
trations up to 10-6 M. Administration of still higher 
doses of mianserin resulted in a contraction of the 
organ. It was not possible to inhibit the contraction by 
mianserin with antagonists of acetylcholine,hiStamine, 
5-HT or <>- and P-adrenoceptor agonists. Inhibition of 
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Fig. 6a, b, c. Receptor protection by mianserin towards Ach 
and 5-HT-induced contractions of: the isolated rat stomach 
fundus preparation against inhibition by phenoxybenzamine 
(dibtnz.) (fig. 6a), cyproheptadine (fig. 6b), and methyser-
gide (fig. 6c). Ach = 10--4M acetylcholine, 5-HT = 10-5 M 
serotonin, mians. = 10-4M (fig. 6a), 10-u M (fig. 6b, c) mian-
serin, methyserg. = 10-5 M methysergide, cyprohept. = 
10-5 M cyproheptadine. Mianserin was administered 5 min 
prior to phenoxybenzamine, cyproheptadine or methysergide. 
An extensive description of the experimental procedure is 
given in Materials and methods. Downwards arrows above the 
curves indicate washing of the preparation. 
the mianserin-induced contraction by chlorpromazine 
was attributed to a non-specific spasmolytic action, 
since the same concentration of chlorpromazine also 
inhibited the response of the fundus to BaCl,. There· 
fore the contraction of the fundus by mianserin is pos-
sibly the result o~ a direct action on the smooth muscle 
cell membrane. Because of the absence of a spasmogen-
ic action of the open diamine analogue of mianserin, a 
piperazine ring structure seems to be necessary for 
the spasmogenic activity. The actions of both 5 -HT 
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and tryptamine on smooth muscle are mediated by 
two types of receptors according to Gaddum (1957): 
the M- and D-types, on the basis of their antagonism 
by morphine and phenoxybenzamine, respectively. 
The rat fundus contains exclusively the D-type of 
tryptamine receptor (Offermeier and Ariens, 1966). 
Nevertheless mianserin was a potent antagonist of 
5-HT in the isolated rat uterus with a pA2 value of 
8.0 ± 0.3 (Vargaftig et al., 1971), but no influence of 
mianserin could be found on the response of the rat 
fundus up to a concentration of 10-6 M. This suggests 
a difference between the receptors in the two tissues. 
However, the potency of cyproheptadine towards the 
response to 5-HT in both organs was similar: the pA2 
value of cyproheptadine on the rat uterus was 
8.4 ± 0.1 (Vargaftig et al., 1971) and on the rat fun-
dus 8.04 ± 0.08. 
Barlow and Khan (1959b) pointed to the differ-
ence in sensitivity of both preparations with respect 
to the antagonistic activity using analogues of 5-HT 
on the rat fundus and uterus. They found that in 
general the effects on the rat uterus and stomach fun-
dus preparation were not dissimilar, although there 
were substantial differences. They concluded, that it 
is not justified to extend the characteristics of the 
action at one site to another site. The difference in 
activity of mianserin towards 5-HT in the rat uterus 
and rat stomach fundus is in line with this conclusion. 
Because of the difference in the effects of cyprohep-
tadine and mianserin on the response to 5-HT of the 
fundus, factors other than rigidity of the antagonist 
molecule and an intersection angle of 120° between 
the planes formed by the aromatic nuclei are possibly 
important for high anti-serotonin activity. 
Although it is not possible to ascribe an anti-
serotonin action for higher concentrations of mian-
serin, because of its spasmogenic action, administra-
tion of mianserin prior to phenoxybenzamine, methy-
sergide or cyproheptadine prevents to inhibition of 
the response to 5-HT of the rat fundus. According to 
Ariens (1964) receptor protection can only be ob-
tained with competitive antagonists. Mianserin is a 
competitive antagonist of Ach on the rat fundus, 
which is in line with its receptor protective activity 
towards Ach. The 5-HT receptor protection by mian-
serin seems to be in conflict with this view unless the 
affinity of mianserin towards the tryptamine receptor 
Fig. 7. Conformation of the hybrid state of dibenzyline re-
sulting in a 'phenylethylamine' alignment at the receptor. 
The electrons of the phenyl group, by interacting with site B 
of the receptor surface secure the molecule, fixing it in the 
right position for alkylation of the receptor site A by the 
N-ethylimine ion (Belleau, 1958). 
is masked by its spasmogenic action. Phenoxybenza-
mine exerts its irreversible antagonism, according to 
Belleau (1958), by interaction with two sites on the 
cell membrane called A and B (fig. 7). Site B is the 
attachment site of the phenyl group of phenoxybenza-
mine fixing the molecule in the right position for the 
alkylation of site A by the N-ethylimine ion. 
Mianserin might prevent alkylation of the 5 -HT recep-
tor by interference with the attachment of the phenyl 
group of phenoxybenzamine at site B of the cell 
membrane in this way protecting site A from alkyla-
tion. Phenoxybenzamine does not inhibit the mian-
serin-induced contraction of the rat fundus. This im-
plies, that the interaction of mianserin with site B 
should be of no importance for its spasmogenic ac-
tion. The observation, that the piperazine ring is 
important for the spasmogenic action of mianserin is 
in accord with this conclusion. Remarkable was the 
receptor protection of 5-HT by the a-adrenolytic 
piperoxan. For piperoxan no competitive antagonism 
towards 5-HT on the rat fundus is described. Accord-
ing to Offermeier and Ariens (1966), it even poten-
tiated the 5-HT-induced contractions of the rat fun-
dus by preventing the inhibitory action of 5-HT on 
0::-adrenoceptors. Apperently piperoxan is able to 
prevent the alkylation of the tryptamine receptors by 
phenoxybenzamine in some other way than by inter-
action with the tryptamine receptors. This means, 
that piperoxan might have prevented an inhibitory 
action of mianserin on tryptamine receptors in a simi-
lar manner as phenoxybenzamine. 
A.L. f"rankhuyzen, l.L. Bonta, Tryptami11e and 5-HT antagonism on rat fundus strips 49 
A fundamental role is ascribed to membrane-
bound Ca2 + in the excitation-contraction coupling. 
(LUHman, 1970). A situation comparable with the 
one described here, i.e. receptor protection provided 
by mianserin and piperoxan to tryptamine receptors, 
is the ability of )3-adrenolytics to protect events me· 
diated by a-adrenoceptors against inactivation by irre-
versible <>-adrenolytics (Kohli and Ling, 1967; Patil et 
a!., !968). This mutual interaction appeared to be 
related to the ability of the antagonists to interact at 
a specific Ca 2 +-binding site. A definite association of 
2-halogenoethylamines with a specific Ca 2 +-binding 
site has been described (Moran eta!., !970). An alter-
native explanation would be, that the receptor pro-
tection afforded by mianserin and piperoxan towards 
inhibition by phenoxybenzamine of the response to 
5-HT, without showing affinity towards the trypta-
mine receptor, might possibly be related to an inter-
action with membrane Ca 2 +-binding sites. 
The tryptamine- and 5-HT-induced contractions of 
rat fundus strips were similarly affected by cyprohep-
tadine (fig. 3b,c). Preincubation of strips with cypro-
heptadine resulted in a shift to the right of both log 
dose-response curves. Cyproheptadine was however 
more then ten times as active against 5-HT-induced con-
tractions than tryptamine.ln contrast to 5-HT the shift 
to the right of the log dose-response curve of trypta-
mine was not accompanied by a decrease of the maxi-
mal contraction height. These two observations possi-
bly indicate a subsidiary action of tryptamine on 
other than the classical D-tryptamine receptors. 
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ERRATUM 
On page (44), right column, line 11-12 should read: 
organ. This is shown in all three figures by the elevated 
baselines of the curves. The results of the experiments with 
cyproheptadine and mianserin are summarized in table 1. In 
this tab 1 e are 1 is ted the pA 2 and pD2 va 1 ues of mi anseri n 
and cyproheptadine with respect to the response to ACh, 5-HT 
and tryptamine. From this table it can be seen, that the pA2 
of mianserin towards ACh is considerably lower than of 
cyproheptadine. From the same table it can be seen ....... . 
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A.L. FRANKHUIJZEN and l.L. BONTA, Receptors involved in the action of 5-HT and tryptamine on the isolated 
rat stomach fundus preparation, European J. PharmacaL 26 (1974) 220-230. 
Participation of C!-adrenoceptors in the effects of 5-HT and tryptamine on the isolated rat stomach fundus 
preparation was investigated. The effects of recognized anti-5-HT agents were also investigated to determine whether 
or not the same type of receptors was involved in the response of the rat fundus to S~HT and tryptamine. 
Mcthysergide was shown to be a very ac-dve, slowly reversible inhibitor of the S~HT~induced contractions. The 
degre~ of inhibition was dependent on the time of pre~incubarion and reached its maximum after approximately 2 
hr. 
The a:-adrenolytlc agent piperoxan appeared to be a competitive antagonist of S~HT. Piperoxan was able to 
prevern or reduce the anti~5~HT activity of mianserin, cyproheptadine and methysergide, indicating a common site 
of action. AU antagonists affected the S~HT conuactions more than those induced by tryptamine. It is concluded, 
that the effect of S~HT on the isolated rat stomach fundus is the result of an interaction of S~HT with one type of 
receptor. This receptor probably is the classical D~tryptamine receptor. The response to tryptamine is the result of 
an interaction by tryptamine with two different types of receptors. One type of receptor is identical to the receptor 
mediating the response to 5~HT, whilst the other type of receptor is more resistant to inhibition by methysergide, 
piperoxan, cyproheptadine or mianserin, and might be identical with the PRT~receptor, described earlier as being 
resistant to inhibition by phenoxybenzamine. 
Phenoxybenzamine-ResistanT (PRT) receptor 
Stimulatory a·adrenoceptor 
A..nti.~5-HT 
1. Introduction 
The potency of mianserin in counteracting the 
responses to S~HT in a number of in vivo and in vitro 
pharmacological preparations was comparable to 
cyproheptadine (Vander Burget al., 1970; Vargaftig 
et a1., 1971 ). In contrast to cyproheptadine, mianse-
rin failed to inhibit the 5-HT- and tryptamine-induced 
contractions of the isolated rat stomach fundus prep~ 
aration (Frankhuijzen and Bonta, 1973). These ex-
periments were performed in the presence of the 
* This paper comprises part of a Doctors thesis in Pharma-
cology to be submitted by A.LF. at the Erasmus Universi~ 
ty Rotterdam. 
D-Tryptamine receptor 
Anti~ tryptamine 
Methysergide 
Piperoxan 
a:~adrenolytic piperoxan to prevent the inhibitory ac-
tion of 5-HT on a~adrenoceptors (Offermeier and 
Ariens, 1966). In receptor~protection experiments, 
both mianserin and piperoxan were able to prevent 
the inhibition of the response to 5-HT by phenoxy-
benzamine (Frankhuijzen and Bonta, 1973). Accord-
ing to Ariens et al. (1964) non-competitive antago-
nists are not able to protect specific receptors against 
irreversible blockade by phenoxybenzamine. From 
the literature it is known that the D-tryptamine re-
ceptor in some respects bears resemblance to a~adre~ 
noceptors. Vane (1960), Innes (1963) and Innes and 
Kohli (1969) described excitatory effects of sympa-
thomimetic amines which they ascribed to an action 
on S~HT receptors. On isolated strips of cat spleen 
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contractions due to 5-HT seemed to be mediated by 
adrenoceptors (Innes, 1962). With respect to the iso· 
lated rat fundus Abramets (1969) concluded from 
cross-tachyphylaxis and receptor-protection experi-
ments, that the D-tryptamine receptor and the a:-adre-
noceptor were very similar. 
One of the possibilities proposed to explain the 
apparent contradictory results with mianserin and 
piperoxan was that the a-adrenolytic properties of 
mianserin (Saxena et al., 1971) and of piperoxan in 
some way might be involved (Frankhuizen and Bonta, 
1973). The aim of the present experiments was to 
investigate the possible role of a:-adrenoceptors in the 
mediation of the effect of 5-HT on the rat fundus. In 
view of this and the above mentioned concept of 
Ariens et a!. (1964) with respect to the receptor 
protection, we repeated the experiments described by 
Offermeier and Ariens in which they investigated the 
influence of piperoxan on the response of the rat 
fundus to 5-HT. 
The anti-5-HT drug, methysergide was found to 
have no adrenolytic action (Von Fanchamps et a!., 
1960). This property of methysergide made it very 
suitable for the investigation of the possible participa-
tion of a:-adrenoceptors in the response of the rat 
fundus to 5-HT. 
In addition we looked to determine whether or 
not piperoxan affected the inhibition of the response 
to 5-HT and of tryptamine by several recognized 
anti-5-HT drugs. From our own experiments (Frank-
huijzen and Bonta, 1973) and from literature (Barlow 
and Khan 1959a,b; Barlow, 1961; and Winter and 
Gessner, 1968) indications can be found for an action 
of tryptamine on other than D-tryptamine receptors. 
We investigated this possibility further by comparing 
the effects of the antagonists towards the responses 
of the rat fundus to 5-HT and to tryptamine. 
2. Materials and methods 
2.1. Preparation of the isolated rat stomach fUndus 
strips 
Experiments were carried out on rat stomach 
fundus strips from male albino Wistar rats weighing 
200-300 g, killed by decapitation. The stomach was 
dissected and strips were cut as described by Vane 
(1957). 2 strips were cut from each fundus. The strips 
were set up in an organ bath at 37° C containing 
Tyrode solution, bubbled with a gas mixture contain-
ing 95% 0 2 -5% C02 . The composition of the Ty-
rode solution was (mM): NaCI 136.8, KCI2.7, CaCI2 
1.8, MgCI2 1.6, NaH2 P04 0.4, NaHC03 I 1.9 and 
glucose 5.6. Contractions were recorded with a Har-
vard electronic recording module. One end of a strip 
was attached to a lever of a Harvard Heart/Smooth 
muscle transducer loaded with 1 g weight. Before 
testing, the strips were allowed to equilibrate for 60 
min, and during this period the bathing fluid was 
changed every 15 min. During the experiments, the 
bathing fluid was changed every 5 min. In all experi-
ments the cumulative dose-response technique was 
used as described by Van Rossum {1963). Dose-
response curves were recorded after a 25 min interval, 
the same agonist being administered every 50 min. In 
this way constant responses were obtained and no 
tachyphylaxis was observed to 5-HT. At the end of an 
experiment one dose-response curve was recorded 
for tryptamine. This procedure was chosen because, 
after the administration of high doses of tryptamine, 
the organ did not return to its original baseline even 
after I hr, or after stretching the tissue. The experi-
mental procedure for a typical experiment is shown 
in fig. I so as to illustrate the exact scheme of drug 
administration. 
2.2. Evaluation of antagonism 
pA2 and pD'2 values were calculated according to 
the method of Ariens eta!. (1956) and VanRossum 
(1963). A pA2 value indicates the affinity of a com-
petitive antagonist for the receptor and is denoted as 
the negative logarithm of the molar concentration of 
the antagonist which causes a 2-fold increase of the 
agonist concentration to obtain the same response. A 
pD'2 value indicates the affinity of a non~competitive 
antagonist for the receptor, and is denoted as the 
negative logarithm of the molar concentration of the 
antagonist which causes a 50% reduction of the maxi-
mal effect of the agonist. Although the pA2 and pD' 2 
values are defined upon the assumption that an equi-
librium state has been reached, pA2 and pD'2 values 
are also used in the experiments with methysergide in 
which the equilibrium state is not reached. In these 
experiments the parameters however only express the 
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tyrode 
tyrode 
+ 
-5 piperoxan (10 M) 
tyrode 
+ 
-5 
piperoxan ( 10 M) 
+ 
antagonist 
L_______..J 
25 min. 
Fig. 1. Scheme of drug administration, illustrating the experimental procedure used. After 1 hr of equihbrati~n of the tissue, 2 
contractions to Ach were recorded, followed by cumulative dose-response curves every 25 min of resp. Ach and 5-HT. A 
dose-response curve for tryptamine was recorded at the end of the experiment. Ach6 = acetylcholine, 10-6 M. The antagonists 
were dissolved in the Tyrode solution bathing the tissue. 
degree of antagonism, although the values are calcu-
lated from equations valid only at equilibrium. Stu-
dent's t-test was used for the statistical evaluation of 
the results. 
2.3. Drugs 
The following drugs were used: acetylcholine 
iodide (Fluka, A.G.), serotonin creatinine sulphate 
(Fluka A.G.), tryptamine hydrochloride (Fluka A.G.) 
methysergide hydrogen maleinate (Deseril, Sandoz), 
mianserin hydrochloride (Organon), cyproheptadine 
hydrochloride (Periactin, Merck Sharp and Dohme) 
and piperoxan (May and Baker). The solution of the 
drugs in Tyrode was prepared on the day of the 
experiment. Drugs were added to the 5 ml organ bath 
in a volume of 0.1 mi. The antagonists were dissolved 
in the stock Tyrode solution bathing the strips. All 
concentrations mentioned refer to the final concen~ 
!ration of the drug in the organ bath and are express-
ed in terms of molarity. 
3. Results 
3.1. Influence of methysergide on the responses to 
Ach, 5-HT and tryptamine 
Methysergide, in a concentration of HT9 M, had 
no effect on the Ach-induced contractions of the 
isolated rat stomach fundus preparation, even after 2 
hr pre-incubation of the strips with methysergide. 
The same concentration of methysergide inhibited 
the 5-HT-induced contractions after only 5 min pre-
incubation (fig. 2a). The 5-HT log dose-response 
curve was shifted to the right in the presence of 
methysergide. This shift was accompanied by a de-
crease of the maximal height of the curve. Both 
effects of methysergide on the 5-HT curve increased 
when the pre~incubation time was extended. The time 
dependence of the degree of inhibition of the maxi-
mal contraction height of 5-HT by methysergide is 
shown in fig. 2b. From this figure it can be seen that 
a maximal degree of antagonism was obtained after 
approximately 2 hr pre-incubation with methyser-
gide. This long period of time necessary for the devel-
opment of maximal inhibition of the response of the 
fundus to 5-HT is in accordance with results obtained 
by Barlow and Khan (1959a). 
The tryptamine~induced contractions were also 
inhibited by methysergide (fig. 3). Pre-incubation 
with methysergide resulted in a shift of the trypt-
amine curve to the right. The maximal contraction 
height of tryptamine was however much less affected 
by methysergide compared with 5-HT. In table I, are 
listed the pA2 and pD' 2 values of methysergide to-
wards both 5-HT and tryptamine at different pre-
incubation times of methysergide. From this table it 
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Fig. 2. (a) Inhibition of the response of the rat fundus to 5-HT by methysergide (10-9 M); influence of the pre-incubation time 
with methysergide .• ____.Log dose~response curve of 5-HT alone, •- id. with methysergide (1o-9M) administered 5 min 
prior to 5-HT, or o-----o id. 15 min or o--o id. 30 min or o----o id. 60 min or-..A-.&id. 120 min. Each curve represents 
the mean of 20 experiments. The vertical bars indicate the S.E.M. (b) Dependence of the percentage inhibition of the maximal 
response of the rat fundus to 5-HT on the pre-incubation time with methysergide (11T9 M). Each point of the curve represents the 
mean value± S.E.M. (indicated by vertical bars) of 20 experiments. 
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Fig. 3. Influence of methysergide (10""9 M) on the response of 
the rat fundus to tryptamine; influence of the pre-incubation 
time with methysergide. •--• Log dose-response curve of 
tryptamine alone, •--• id. with methysergide (10""9 M) 
administered 5 min prior to tryptamine, or 6~6 id. 15 min. 
or O--D id. 30 min, or o--O id. 60 min or .._ __ ... id. 
120 min. Each curve represents the mean of 10 experiments. 
The vertical bars in the figure indicate the S.E.M. 
Table 1 
The effect of the pre-incubation time of methysergide on the 
pA2 and pD' 2 value of methysergide towards the response of 
the rat fundus to 5-HT and tryptamine. The values given in 
the table represent the mean ± S.E.M. of 20 (5-HT) or 10 
(tryptamine) experiments. 
Pre-incu- Agonist 
bation 
time of 5-HT Tryptamine 
methy-
sergide 
(10-9 M) 
pA, pD2 pA, pD2 
(min) 
5 8.9 ± 0.4 8.0 ± 0.2 8.4±0.7 7.7 ± 0.3 
15 9.1 ± 0.3 8.39 ± 0.08 8.8 ± 0.6 7.9 ± 0.2 
30 9.5 ± 0.5 8.88 ± 0.05 10.4 ± 0.2 8.3 ± 0.2 
60 10.1 ± 0.3 9.27 ± 0.08 10.5 ± 0.3 8.4 ± 0.1 
120 10.4 ± 0.4 9.55 ± 0.08 10.6 ± 0.3 8.6 ± 0.1 
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Table 2 
Percentage recovery of the response of the rat fundus to 5-HT from the inhibition by methysergide (1()9 M); influence of 
piperoxan (1 () 5 M). The mean values of the % recovery of the response after the washout of methysergide are given ± S.E.M. The 
numbers of experiments are given in parentheses. 
Pre-incubation time (min) 
of methysergide 
Recovery time (min) after washout of methysergide (10- 9 M) 
oo-' M) 
5 (5) 
15 (7) 
30 (1 0) 
60 (7) 
50 
- 6.3 ±0.4 
- 33 ± 1 
20.0 ± 0.8 
50 in presence 
of piperoxan 
(10-5 M) 
94 ±6 
61 ± 2 
53± 3 
can be seen that there is an increase of the pA2 and 
pD; value of methysergide when the time of pre-incu-
bation is extended. The pA2 values towards 5-HT and 
tryptamine are comparable. The pD; values towards 
tryptamine are however, with the exception of the 
pD; value after 5 min pre~incubation time, signifi~ 
cantly (p < 0.01-0.001) lower than towards 5-HT. 
100 
.~ 
~ 50 
" 8 
0 
·' 
0 
* 
-log (5-HT) 
Fig. 4. Recovery of the response of the rat fundus to 5-HT 
from inhibition by methysergide (10-9 M, 30 min pre-incu-
bation); influence of piperoxan (1()5 M). •--• Log dose-
response curve of 5-HT alone, ..., __ ..., id. with methysergide 
(l(T9 M) administered 30 min prior to 5-HT, or ~:, __ ~:, id. 
50 min after the washout of methysergide, or o--o id. 50 
min after the washout of methysergide, in the presence of 
piperoxan (1()5 M). Each curve represents the mean of 10 
experiments. The S.E.M. are given by the vertical bars in the 
curves. 
100 100 in presence 200 
of piperoxan 
(10-5 M) 
0 ± 0.4 
28 ± 1 
42 ± i 
51± 2 65 ± 2 64 ± 3 
3.2. Recovery of the response to 5-HT from inhibi-
tion by methysergide: influence of piperoxan 
The possibility was investigated as to whether 
methysergide exerted a reversible non-competitive 
type of antagonism towards 5-HT. Therefore the re-
covery of the response of the fundus to 5-HT was 
recorded at different time intervals after washing the 
strips from methysergide (Hf9 M). As a result of 
these experiments, the antagonism of methysergide 
appeared to be of a very slowly reversible type. Even 
200 min after washing the preparation from methy-
sergide the percentage recovery of the maximal con-
traction of the fundus to 5-HT was only 64 ± 3% 
(table 2). The influence of the <>-adrenolytic piper-
oxan on the recovery of the 5-HT response from 
methysergide inhibition was twofold. In the presence 
of piperoxan (HT5 M) the maximum of the 5-HT log 
dose-responses curve was increased (table 2). This 
increase was accompanied hy a shift of the log dose-
response curve to the right (fig. 4). 
3.3. Influence of piperoxan (10-5 M) on the contrac-
tions induced by Ach, 5-HT and tryptamine 
Because of the shift of the 5-HT curve to the right 
in the presence of piperoxan in the recovery experi-
ments, the influence of piperoxan on the response of 
the fundus to 5-HT and tryptamine was investigated. 
Ach was included in these experiments to see whether 
an effect of piperoxan was limited to tryptamine 
receptors or not. 
Administration of piperoxan resulted in a parallel 
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Fig. 5 (a) Influence of piperoxan (10-s M) on the response of the rat fundus to Ach. e-----o Log dose-response curve of Ach 
alone, •-------a id. with piperoxan (1()5 M) administered 20 min prior to Ach, or o-----.o id. 70 min prior to Ach. Each curve 
represents the mean of 80 experiments. The vertical bars in the figure indicate the S.E.M. (b) and {c) Influence of piperoxan 
(10-5 M) on the response of the rat fundus to 5-HT (b) and tryptamine (c). (b) e-----e Log dose-response curve of 5-HT alone, 
•------a id. with piperoxan (10-5 M) administered 45 min prior to 5-HT; (c) e------e log dose-response curve of tryptamine alone, 
•--a id. with piperoxan (1 0"5 M) administered 145 min prior to tryptamine. Each curve represents the mean of 80 (5-HT) or 
40 experiments (tryptamine). The vertical bars in the figures indicate the S.E.M. 
shlft to the right of the Ach log dose~ response curve 
(fig. 5a). The difference between the pD; values 
(0.15 log units) of the Ach curve without, and in the 
presence of, piperoxan was not statistically signifi-
cant, although it was observed in every experiment. 
Furthermore it could be reversed in the absence of 
piperoxan. The response of the fundus to 5-HT and 
tryptamine was much more affected. Pre-incubation 
of strips with piperoxan {lo-s M) for 45 min resulted 
in a parallel shift to the right of the 5-HT log dose~ 
response curve of 0.90 ± 0.07 log units {fig. 5b ). 
Extension of the pre-incubation time of piperoxan 
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Table 3 
pA2 values of piperoxan towards the responses of the rat 
fundus to Ach, 5-HT and tryptamine. The values represent 
the mean ± S.E.M. of 80 (Ach and 5-HT) or 40 (tryptamine) 
experiments. 
Pre-incubation time (min) Agonist 
of piperoxan ( 1 o-5 M) 
(min) 
20 Ach 
70 Ach 
45 5-HT 
95 5-HT 
145 Tryptamine 
pA, 
4.51 ± 0.25 
4.51 ± 0.25 
5.84 ± 0.08 
5.90 ± 0.11 
5.40 ± 0.15 
did not result in a significant increase of the pA2 
value of piperoxan towards 5-HT (table 3). The ac-
tion of piperoxan on the response to tryptamine (fig. 
5c) appeared to be different from that of 5-HT. 
Although pre-incubation with piperoxan resulted in a 
shift of the tryptamine curve to the right, the pA2 
value of piperoxan towards tryptamine was signifi-
cantly (p < 0.001) lower than towards 5-HT (table 
3). Moreover, the slope of the tryptamine curve in the 
presence of piperoxan at 50% of the maximal con-
traction was increased by a factor of 1.5. 
3.4. Influence of piperoxan ( 1 a·s M) on inhibition by 
methysergide of the response to 5-HT and tryptamine 
To obtain information as to whether or not piper-
oxan and methysergide have a common site of ac-
tion, the influence of piperoxan on the methysergide 
Table 5 
inhibition of the contractions induced by 5-HT and 
tryptamine was investigated. 
Pre-incubation of rat fundus strips with methyser-
gide (10-9 M) for 1 hr in the presence of piperoxan 
did not affect the 5-HT log dose-response curve. 
Neither a shift to the right nor a decline of the curve 
was observed as it had been in the absence of pipe-
roxan (fig. 6a). In the case of tryptamine, the inhibi-
tion by methysergide (1 lf9 M) after 2 hr pre-incuba-
tion was largely prevented by piperoxan (fig. 6b ). The 
results of these experiments are summarized in table 
4a and b. In these tables are listed the pD; values and 
the %maximal contraction of, respectively, the con-
tractions induced by 5-HT and by tryptamine, with-
out and in the presence of piperoxan and methyser-
gide separately or in combination. From these tables 
it can be seen that pre-incubation of the fundus strips 
with methysergide in the presence of piperoxan did 
not result in a significant further decrease of the pD; 
values of 5-HT and tryptamine. The decrease of the 
maximal contraction of 5-HT and tryptamine by 
methysergide was largely prevented by piperoxan. 
3.5. Inhibition of the response to 5-HT by cyprohep-
tadine and mianserin: influence of piperoxan 
To determine whether or not the influence of 
piperoxan was limited only to the anti-tryptamine 
actions of methysergide, two other recognized 
D-tryptamine receptor antagonists, mianserin and 
cyproheptadine, were used. It was investigated wheth-
er the actions of these two antagonists were affected 
by piperoxan in a way similar to methysergide. Pre-
Influence of piperoxan (1 U" 5 M) on the pA2 and pD2 values of cyproheptadine and the pA2 values of mianserin towards the 
responses of the rat fundus to Ach, 5-HT and tryptamine. The values given represent the means of 10 experiments± S.E.M. 
Agonist 
Ach 
5-HT 
Tryptamine 
Antagonist 
Cyproheptadine 
pA, 
8.19 ± 0.10 
7.83 ± 0.11 
7.20±0.17 
pD2 
In presence 
of piperoxan 
(lo-s M) 
8.03 ± 0.10 
7.50 ± 0.10 5.70 ± 0.10 
6.87 ± O.!l 
Mianserin 
pA, 
In presence In presence 
of piperoxan of piperoxan 
(lo-s M) (10-s M) 
5.94 ± 0.40 6.05 ± 0.35 
5.43 ± 0.09 7.05 ±0.21 
6.83 ± 0.28 
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incubation of strips with mianserin (10-6 M) for I hr 
in the presence of piperoxan did not affect the 5-HT 
and tryptamine log dose-response curves (Frankhuij· 
zen and Bonta, 1973). Pre·incubation with mianserin 
in the absence of piperoxan resulted in a parallel shift 
to the right of the 5-HT curve, indicating a competi-
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Fig. 6a and table 4a. Influence of methysergide on the re· 
sponse of the rat fundus to 5-HT alone, and in the presence 
of piperoxan (lcr5 M). •--• Log dose-response curve of 
5·HT alone, •--• id. with methysergide (1Cf9 M) adminis· 
tered 60 min prior to 5-HT, or 6--"' log dose-respon.se 
curve of 5·HT in the presence of piperoxan (lcr5 M), or 
•--• id. methysergide (la-9 M) administered 60 min prior 
to 5-HT in the presence of piperoxan (l(r5 M). The values 
given in table 4a and each curve in fig. 6a, represents the 
mean of n experiments ± S.E.M. {in fig. 6a represented by 
vertical bars). 
Table 4a 
n Antagonist Cone. pD'2 %of max. 
(M) (5-HT) contrac-
tion 
88 8.05 ± 0.10 
44 Piperoxan 10-s 7.05 ±0.10 100 ± 1 
12 Methysergide 10-10 7.65 ± 0.15 71 ± 3 
12 Piperoxan+ 10-s 7.10 ±0.15 94 ± 2 
methysergide 10-10 
10 Methys~rgide 10-9 7.20 ± 0.15 42 ± 3 
10 Piperoxan+ 10-5 7.00 ± 0.15 103 ±3 
methysergide 10-9 
tive type of antagonism. The response of rat fundus 
strips to tryptamine in the absence of piperoxan was 
also affected by mianserin. The shift to the right of 
the tryptamine curve was however not parallel as it 
had been for 5-HT. Administration of mianserin re-
sulted in a 2.4-fold increase in the slope of the curve 
at 50% of the maximal contraction height. In the case 
of cyproheptadine, the inhibition of the response of 
the fundus to 5-HT and tryptamine was reduced in 
the presence of piperoxan (table 5). 
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Fig. 6b and table 4b. Influence of methysergide on the re· 
sponse of the rat fundus to tryptamine alone, and in the 
presence of piperoxan (1Cf5 M) •--• Log dose-response 
curve of tryptamine alone, •--• id. with methysergide 
(lcr9 M) administered 2 hr prior to tryptamine, or £';--4 
log dose-response curve of tryptamine in the presence of 
piperoxan (lcr5 M) or •--• id. with methysergide 
(lcr9 M) administered 2 hr prior to tryptamine in the pres· 
ence of piperoxan (1 cr5 M). The values given in the table and 
each curve in the figure represent the means of n experiments 
± S.E.M. (in the figure represented by vertical bars). 
Table 4b 
n Antagonist Cone. pD2 %of max. 
(M) (tryptamine) contrac· 
tion 
40 5.25 ± 0.10 100 
20 Piperoxan 10-s 4.90 ± 0.10 99 ± 3 
10 Methysergide 10-9 3.60 ± 0.15 70 ±3 
10 Piperoxan+ 10-s 4.70 ± 0.15 93 ±4 
methysergide 10-9 
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4. Discussion 
The spasmogenic action of both 5-HT and trypt-
amine is the result of an interaction with specific 
tryptamine receptors. These receptors are classified 
by Gaddum and Picarelli (1957) into two types: M-
and D-tryptamine receptors. TheM-tryptamine recep-
tors are sited in the intramural parasympathetic gan-
glion cell (Brownlee and Johnson, 1963) and are 
blocked by morphine. The D-tryptamine receptors 
are localized in the membrane of smooth muscle cells 
and are blocked by phenoxybenzamine. In the isolat-
ed rat stomach fundus preparation only the D-trypt-
amine type of receptor is present (Vane, 1957; Offer-
meier and Ariens, 1966). This is in contrast to the 
guinea-pig stomach, in which both types of tryptamine 
receptor are present (Yamaguchi, 1972). The contrac-
tion of the rat fundus by 5-HT is believed to be the 
result of an interaction of 5-HT with two kinds of 
receptors: D-tryptamine receptors and inhibitory a-
adrenoceptors, as has been described by 
Offermeier and Ariens (1966). However, according to 
the results of the experiments described in this paper, 
this model for the action of 5-HT on the rat fundus is 
no longer tenable. Methysergide was very active in 
antagonizing the 5-HT-induced contractions of strips 
of the rat fundus without affecting the response to 
Ach. Pre-incubation of the strips with 10·9 M methy-
sergide resulted in a shift to the right of the 5-HT log 
dose~response curve. This shift was accompanied by 
a decrease of the maximal contraction height of the 
curve. The degree of antagonism appeared to be de~ 
pendent on the time of pre-incubation and reached its 
maximum after about 2 hr. One possible explanation 
is, that methysergide exhibits a dualism in antagonism 
(Ariens et al., 1964) with respect to 5-HT, behaving 
as a competitive as well as a non-competitive antago-
nist. However, according to the model for the action 
of 5-HT as proposed by Ariens and Offermeier (1966) 
an alternative explanation would be that a pure com-
petitive antagonism of methysergid~ exists towards 
the interaction of 5-HT with the D-tryptamine recep-
tors. The decrease of the maximal contraction height 
of the log dose~ response curve is then caused by the 
inhibitory action of 5-HT on a:-adrenoceptors becom-
ing more prominent. This possibility was supported 
by the finding that administration of the u-adrenolyt-
ic piperoxan, after washout of methysergide in the 
recovery experiments, resulted in an increase of the 
maximal contraction height to 5-HT. 
Pre-incubation of fundus strips with piperoxan re-
sulted however in a parallel shift to the right of the 
5~HT log dose~response curve, indicating a competi-
tive type of antagonism. This action of piperoxan is 
completely contradictory to the 5-fold potentiation 
of the maxhnal height of the 5-HT curve by pipe-
roxan found by Offermeier and Ariens (1966). In 
their experiments however strips were used from 
which the mucosa was removed, while the experi-
ments described in this paper were performed on 
intact strips. Horn and Zweifach (1963) studied the 
influence of splitting the intact fundus strip into two 
layers at the level of the submucosa on the subse-
quent response to 5-HT. They found that the 5-HT-
induced increase in tension of the serosal strip did not 
differ significantly from the tension increase produc-
ed in the intact strip. This means that the discrepancy 
between the results obtained by Offermeier and 
Ariens and the results presented in this paper cannot 
be explained by a simple difference in the prepara-
tion. The competitive antagonism of piperoxan to-
wards 5-HT is compatible with the previously observ-
ed receptor protection exerted by piperoxan towards 
the 5-HT-induced contraction against the irreversible 
inhibition by phenoxybenzamine (Frankhuijzen and 
Bonta, 1973 ). 
Pre-incubation of strips with piperoxan prevented 
the inhibition of the response to 5-HT by methyser-
gide. This makes it most likely that the site of action 
of both piperoxan and methysergide is the same. This 
means also that methysergide probably exerts an al-
most irreversible competitive type of antagonism to-
wards 5-HT on the isolated rat fundus preparation. 
From experiments similar to those described for piper-
oxan and methysergide, it is concluded that the sites 
of action of mianserin and cyproheptadine are identi-
cal to those of piperoxan and that they also are 
competitive antagonists of 5-HT. 
Comparing the influence of the anti-5-HT agents 
on the response of rat fundus to 5-HT and trypt-
amine, striking differences were found. These differ-
ences were very obvious with piperoxan and mianse-
rin. Administration of these drugs resulted in a paral-
lel shift to the right of the 5-HT log dose-response 
curve. In the case of tryptamine however, this shift 
was not parallel. The slope of the tryptamine log 
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dose-response curve at 50% of the maximal contrac· 
tion height was increased with a factor of about 1.5. 
in the presence of piperoxan and 2.4. in the presence 
of mianserin. If the responses of the rat fundus to 
5-HT and tryptamine are mediated by the same type 
of receptor, administration of piperoxan or mianserin 
should have resulted in a parallel shift to the right of 
the tryptamine log dose-response curve. Because of 
the observed increase in the slope of the tryptamine 
curve after competitive inhibition of the tryptamine 
receptors~ there should be a subsidiary action of 
tryptamine on other than D-tryptamine receptors. 
Responses to tryptamine mediated via other than 
D-tryptamine receptors are described in literature 
(Wooley and Shaw, 1957; Barlow, 1961; Winter and 
Gessner, 1968). All came to the conclusion that al-
though the responses to tryptamine and 5-HT are 
affected by the same classes of antagonists, it is 
apparent, that differences exist with respect to the 
antagonism towards the action of tryptamine and 
5-HT. 
An important difference between tryptamine and 
5-HT is each agent's lipid solubility. The lipid solubili-
ty of 5-HT is very low. Hence 5-HT, unlike trypt· 
amine, is unable to passively enter the cell. Barlow 
(1961) ascribed the differential character of the in· 
hibition of 5-HT and tryptamine either to an interfer-
ence with the transport of tryptamine through the 
cell membrane coupled with an inhibition of the 
D-tryptamine receptor, or the existence of separate 
tryptamine and 5-HT receptors. Provided that the 
effect of tryptamine on the rat fundus is mediated by 
one type of receptor located in the cell membrane, 
inhibition of the transport of tryptamine through the 
cell, or inhibition of MAO, should result in a parallel 
shift to the left of the tryptamine curve. This was 
actually found by Offermeier and Ariens (1966). This 
means that an interference with the transport or 
metabolism of tryptamine cannot be the explanation 
of the increase of the slope of the tryptamine curve 
after incubation with piperoxan or mianserin. 
Except for mianserin and cyproheptadine, there is 
no prominent structural relationship between the 
antagonists used in these experiments. Nevertheless, 
all exerted a competitive type of antagonism towards 
5-HT. This makes it most likely that the response of 
the rat fundus to 5-HT is mediated by only one type 
of receptor. According to the inhibition of the 5-HT 
of receptor. A cording to the inhibition of the 5-HT-
induced contractions by phenoxybenzamine together 
with the receptor protection provided by mianserin 
and piperoxan against the inhibition by phenoxy-
benzamine (Frankhuijzen and Bonta, 1973), this re-
ceptor is of the classical D-type of tryptamine recep-
toL 
From literature it is known that 5-HT shows an 
affinity towards a::-adrenoceptors. This was shown 
amongst others for the rat vas deferens (Offermeier 
and Ariens, 1966; Nishino et al., 1970), isolated strips 
of cat spleen. (Innes, 1962) and also for the rat 
stomach fundus (Abramets, 1969). A possible expla-
nation for this action is that the spatial arrangement 
of the a::-adrenoceptor and the D-tryptamine receptor 
is very simi,lar. Another possibility is, that the action 
of 5-HT is mediated by an e<-adrenocertor with ex-
citatory properties. This type of receptor is described 
in the literature (Gagnon, 1970; Gagnon and Belisle, 
1970; Haffner, 1971; Baily, 1971; and Guimaraes, 
1969), and also for the rat fundus (Ogle and Wong, 
1971). An interaction of 5-HT with such a type of 
receptor is more likely, since many of the a::-adreno-
lytics posess anti-5-HT properties. Regarding the an-
tagonists we used, piperoxan is a recognized a-adreno-
lytic, while a-adrenolytic properties of rnianserin have 
been described (Saxena et al., 1971). No such proper-
ty has been described for methysergide (Von Fan-
champs et al., 1960). a-Adrenolytic properties have 
been described for structurally closely related com-
pounds such as 2-bromo-LSD (Palmer and Burks, 
1971 ;Krishnamurty, 1971). Although in the literature 
several arguments can also be found against the possi· 
bility of D-tryptamine receptors to be similar to e<-
adrenoceptors with stimulating properties (Gagnon, 
1972), it is not possible to exclude this possibility 
from the experiments described in this paper. 
In conclusion, the results presented indicate that 
the response of the isolated rat stomach fundus prep-
aration to 5-HT is mediated by only one type of 
receptor. This receptor probably is the classical 
D-tryptamine receptor, although the possibility of a 
stimulant o:-adrenoceptor is not excluded. The re-
sponse to tryptamine is mediated by the same type of 
receptor. A subsidiary action of tryptamine on a dif-
ferent kind of receptor is described. 
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ABSTRACT 
ANALYSIS OF ERGOTAMINE - 5-HT INTERACTION ON THE 
ISOLATED RAT STOMACH PREPARATION 
Abraham L. FRANKHUIJZEN 
Department of Pharmacology, Medical Faculty, 
Erasmus University, Rotterdam, The Netherlands 
The effect of ergotamine on the isolated rat stomach and its influence 
on the response to.ACh and 5-HT were investigated. The log dose-response 
curve of ergotamine was bell-shaped. Extension of the incubation time of 
ergotamine resulted in a parallel shift to the left of the curve. The 
response to ergotamine was inhibited by methysergide and piperoxan. 
Incubation with ergotamine resulted in a decrease of the pD2-value of 
5-HT together with a marked suppression of the maximum of the 5-HT 
curve. The response to ACh was affected in accordance with the pre-
diction of an action of ACh and ergotamine on different receptors. The 
prolonged receptor stimulation by 5-HT or ACh resulted in a decrease of 
the apparent affinity towards their receptors. Incubation with ACh 
resulted in a parallel shift to the right of the 5-HT curve. However, 
no inconsistency with the theoretical prediction of an action on 
separate receptors was observed with the ACh curve in the presence of 
5-HT. It is concluded that ergotamine is a partial agonist on the D-
tryptamine receptors of the isolated rat stomach. The marked decrease 
of the maximum of the 5-HT curve by ergotamine is probably caused by 
the slowly reversible character of its antagonism. The parallel shift 
to the left of the ergotamine curve with the extension of the 
17 
incubation time and the persistence of its antagonism both are 
probably caused by a slow diffusion into and from the biophase. 
1. INTRODUCTION 
It has been argued that ergotamine may owe its therapeutic effectiveness 
in migraine to a selective constriction of the external carotid vessels 
(Saxena and de Vlaam-Schluter, 1974). The smooth muscle stimulatory 
action of ergot alkaloids seems to be mediated either by a-adrenoceptors 
(Innes, 1962) or by D-tryptamine receptors (Dy~r, 1974). Another type 
of tryptamine receptor different from the classical D-tryptamine recep-
tor, accord·ing to the classification by Gaddum and Picarell i (1957), 
seems to be involved in the mediation of the constrictor response of 
the external carotid vessels to ergotamine and 5-HT (Saxena and de 
Vlaam-Schluter, 1974) and probably also to the anti 5-HT drugs methy-
sergide (Saxena, 1974) and mianserin (Saxena et al., 1971). 
Tryptamine receptors different from the classical D-tryptamine receptors 
also seem to be present in the isolated rat stomach (Winter and Gessner, 
1968; Frankhuijzen and Bonta, 1974a, b), although the response to 5-HT 
appears to be mediated only by the classical D-tryptamine receptors 
(Frankhuijzen and Bonta, 1974b). 
Because of the importance ascribed to the agonistic response to 
ergotamine in migraine therapy and the occurrance of a non 0-type of 
myogenic tryptamine receptor it seemed of interest to investigate in 
detail the effect of ergotamine on the isolated rat stomach preparation 
and its influence on the response to 5-HT. 
2. MATERIALS AND METHODS 
2.1. 
The 
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Experimenta~ preparation 
rat stomach strips were prepared according to the method described 
by Vane (1957) from Wistar adult male rats weighing 200-300 g killed 
by decapitation. Two strips were cut from the ruminal part of the 
stomach: one set of strips served as a blank in order to correct the 
responses of the other strips for changes in sensitivity and tone. The 
strips were set up in a 5 ml organ bath maintained at 37°C containing 
Tyrode solution and bubbled with a gas mixture containing 95% 
o2 - 5% co2. The Tyrode buffer solution was of the following composition 
(mM): NaC1 136.8; KC1 2.7; CaC1 2 1.8; MgC1 2 1.6; NaH2Po4 0.4; NaHC03 
11.9 and glucose 5.6. The contractions were amplified 3 times using a 
Harvard heart/smooth muscle transducer loaded with 1.0 g weight and 
recorded with a Harvard electronic module 350. 
Usually cumulative dose-response curves according to the method of 
Van Rossum (1963) were obtained. Only in the case of the ergotamine 
curves in which each concentration of ergotamine was left in contact 
with the tissue for a definite time the single dose-response technique 
was used. The total volume of the agonist added to the organ bath did 
not exceed 15% of the bath volume. The procedure used in the experiments 
was essentially the same as described before (Frankhuijzen and Bonta, 
1974b). 
2.2. Theoretical log dose-response curves 
Two different types of drug-receptor interactions are involved in the 
experiments to be presented: "competitive interaction", in which two or 
more drugs act on one receptor system and "functional interaction" in 
which two or more drugs act on different independant receptors. The 
appropriate equations used for the calculations of the log dose-response 
curves were derived from those given by Ariens (1964). In some 
instances it was necessary to use the logistic function (Parker and 
Waud, 1971): 
a 
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where a= intrinsic activity, A= concentration of drug A, KA = disso-
ciation constant of the drug-receptor complex and p = exponent to 
admit correction for the slope of the dose-response curve experimentally 
found. The exponent was graphically determined by plotting 
log(EM- E/EA) against -log A. 
2. 3. Drugs 
The following drugs were used: acetylcholine iodide (Fluka A.G.), 
serotonin creatinin sulphate (5-HT, Fluka A.G.), ergotamine tartrate 
(Gynergeen, Sandoz), methysergide hydrogen maleinate (Deseril, Sandoz), 
piperoxan chloride (May and Baker). The solutions of the salts of the 
drugs were prepared freshly on the day of the experiment. Drug 
solutions were added to the 5 ml organ bath in a volume of 0.1 ml. All 
concentrations mentioned refer to the final concentration of the drug 
in the organ bath and are expressed in terms of molarity. 
3. RESULTS 
3.1. Influence of ergotamine on the response to 5-HT. 
Incubation during 70 min of rat stomach strips with ergotamine (Fig. 1) 
resulted in a dose-dependant contraction, the maximum of which was 
reached at a bath concentration of about 10-7M. A further increase to 
10-6M of the concentration did not result in a higher contraction. The 
response even seemed to be diminished. 
The influence of the incubation with ergotamine on the 5-HT log dose-
response curve was twofold. The pD 2-value of 5-HT decreased with in-
creasing ergotamine concentration together with a marked decrease of 
the maximum of the 5-HT curve (Table 1). 
Both the elevation of the tone of the preparation and the inhibition 
of the response to 5-HT persisted for more than 2 hr after the removal 
of ergotamine from the bathing fluid. 
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Fig. 1. Influence of incubation during 70 min with ergotamine 
on the response of rat stomach strips to 5-HT. o---e Log dose-
response curve of 5-HT; o----o id. in the presence of ergot-
amine (10-9M); o---o id. -9 3 .10 M; 
--
id.' 10 -SM; !!.-!!. 
id . , 10-7M· , i.-it id.' 10- 6M. Each curve represents the mean 
out of 10 experiments. The S.E.M. in each point of the curve is 
indicated by vertical bars. 
Base- Ergotamine bath % max .. contr .. 
pD2 (5-HT) J.ine 
0 ± 
11 ± 
16 + ~ 
40 ± 
51 ± 
42 ± 
concentration (M) of 5-HT 
0 0 100 + 0 8.10 ± 0.05 
4 10-9 98 + 2 7.90 ± 0. 10 
6 3.10-9 86 + 3 7.80 + 0.15 
6 10- 8 8o ± 4 7.60 ± 0.15 
4 10- 7 6o + 4 
6 10-6 51 + 6 
Table 1. Influence of incubation during 70 min with ergotamine 
on the response of rat stomach strips to 5-HT. The values listed 
under base-line are expressed in% maximal contraction of 5-HT. 
All values given in the table represent the mean out of 10 exp. 
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3. 2. Contraction of the rat stomach strip by ergotamine 
The possibility of a partial agonistic action of ergotamine on D-
tryptamine receptors was investigated using the cumulative dose-response 
technique. The ergotamine log dose-response curve was bell-shaped 
reaching its maximum at a bath-concentration of 3.10-6M (Fig. 2). 
"'1 ] 
Fi~ Contraction of strips from rat stomach by ergotamine. 
~ Log dose-response curve of 5-HT; .i-4 id., of ergotamine; 
ll-1:, id., after 20 min incubation with methysergide (10- 8M); 
a---D Log dose-response curve of ergotamine. Each concentration 
of ergotamine as indicated by the points of the curve was left 
in contact with ihe tissue for 20 min; o---o id., for 45 min; 
~ id., for 70 min. Each curve represents the mean out of 
10 experiments. The S.E.M .. in each point in the curve is 
indicated by vertical bars. 
Further increase of the ergotamine concentration resulted in a decrease 
of the contraction height. Incubation during 20 min with methysergide 
(10-8M) resulted in an almost complete blockade of the ergotamine 
induced contraction. 
A remarkable decrease of the pD 2-value of ergotamine of 1.75 ~ 0.23 log 
units was observed in comparison with the curve obtained with single 
doses of ergotamine left in contact with the tissue for 70 min. In order 
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to confirm the influence of the duration of incubation on the pD2-value 
of ergotamine, single dose-response curves were recorded after incubat-
ion with ergotamine for 20 and 45 min respectively. From Fig. 2 it can 
be seen that the ergotamine log dose-response curve was gradually 
shifted to the left with increasing incubation times. No significant 
change of the maximum height was observed, resulting in an increase of 
the pD2-va1ue of ergotamine. 
J. 3. -8 Influence of ergotamine (10 M) on the response to ACh; comparison 
with its influence on the response to 5-HT. 
During the incubation of the stomach strips with ergotamine the preparat-
ion is up till 70 min in a continuous state of contraction. The possibi-
lity was therefore investigated as to whether the continued elevated 
tone of the preparation did influence the contractility and/or sensiti-
vity of the preparation. For this purpose cumulative dose-response 
curves of ACh and 5-HT were recorded after the incubation with one 
concentration of ergotamine (10-8M). 
Fig. 3a. Influence of incubation during 45 min with ergotamine 
(10- 8M) on the response to ACh. ~ Log dose-response curve 
of ACh; o--o id. , after incubation with ergotamine; c---o 
id., theoretical curve. 
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The log dose-response curves obtained experimentally were compared with 
the theoretical curves assuming a functional interaction between ergot-
amine and ACh (Fig. 3a) and a competitive type of interaction between 
ergotamine and 5-HT (Fig. 3b). 
Fig. 3b. Influence of incubation during 70 min with ergotamine 
(1o- 8M) on the response to 5-HT. o---e Log dose-response curve 
of 5-HT; o---o id., in the presence of ergotamine (10- 8M); 
1>---<l id. , theoretical curve; A-- A. id. , theoretical curve 
corrected for the decline in maximal contraction height. 
th respect to the ergotamine-5-HT interaction actually two theoretical 
log dose-response curves are given. In order to make a better comparison 
possible between the curve expei"imentally found and the theoretical 
curve, the original theoretical curve was transformed to a curve with 
the same maximum as the one experimentally obtained. The assumption was 
made that the decrease of the maximum of the 5-HT curve experimentally 
obtained was caused by the irreversibility of the action of ergotamine. 
The theoretical curve and the ACh-curve experimentally obtained were not 
significantly different. The mean value of the pD 2 of 5-HT in the 
presence of ergotamine was 7.60 :_ 0.25. A po2-value of 7.35 was expected 
from the theory. Although no S.E.M. was calculated for the theoretical 
pD2-va1ue, the observed difference in pD2-value was nevertheless not 
appreciable. 
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;;, 4. Influence of incubation with 5-HT (10-8M) on the response to 
ACh and 5-HT. 
In order to see as to whether the prolonged receptor stimulation by 
ergotamine had affected the response of the tissue to ergotamine and its 
effect on the 5-Hr induced contraction, the same experiments were per-
formed in which the effect of prolonged incubation with 5-HT on the 
response to ACh and 5-HT was investigated. A bath-concentration of 5-HT 
was chosen which was expected to result in a similar elevation of the 
tone of the preparation as with ergotamine (10-8M). In order to see 
whether aspecific effects would occur, the influence of the incubation 
with 5-HT (10-8M) was also investigated on the ACh induced response. 
Both the theoretical curve, assuming a synergistic action between 5-HT 
and ACh, and the curve experimentally obtained are depicted in Fig. 4a. 
Fig. 4a. The influence of incubation with 5-HT (10- 8M) during 
45 min on the response of rat stomach strips to ACh. o---e Log 
dose-response curve of ACh; o---o id., in the presence of 5-HT 
(10- 8M); ~:~---a id., theoretical curve. 
No significant difference was observed between the pD2-va1ue and the 
% maximal contraction of both curves. The incubation during 70 min with 
5-HT (10-~) resulted in a marked shift to the right of the 5-HT log 
dose-response curve as compared with the theoretical curve (Fig. 4b). 
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Fig. 4b. Influence of incubation of rat stomach strips during 
70 min with 5-HT (10-8M) on the response to 5-HT . .---.Log 
dose-response curve of 5-HT; o-:--o id. , after incubation with 
5-HT (10- 8M); ..---o id., theoretical curve. 
Only a slight reduction of the maximum of the curve was observed, which, 
however, was not significant. 
3. 5. Inf1uenae of incubation with ACh 
and 5-HT. 
-7 (10 M) on the response to ACh 
it was investigated whether the tachyphylaxis towards the response to 
5-HT of rat stomach strips after the prolonged exposure to 5-HT was 
specific for 5-HT or whether it was a more general phenomenon. For this 
reason the influence of the incubation with ACh of the preparation on 
the response to ACh and 5-HT was examined. As with ergotamine and 5-HT 
a concentration of ACh was chosen which was expected to result in a 
comparable increase in tone of the preparation. Again the curves 
experimentally obtained were compared with those calculated from the 
relevant equations. The incubation during 45 min with ACh (10-7M) 
resulted in a parallel shift to the right of the log dose-response curve 
of ACh, if compared with the theoretical curve, without significantly 
affecting the maximum of the curve (Fig. Sa). This resulted in a highly 
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significant decrease of tile pD 2-value of 0.55 + 0.16 log units. 
Fig. Sa. Influence of incubation during 45 min with ACh 
-7 (10 M) on the response of rat stomach strips to ACh. 
~Log dose-response curve of ACh; o---o id., after 
incubation with ACh (10- 7M); ll---;:1 id., theoretical 
curve~ 
Regarding the influence of incubation with ACh on the response to 5-HT 
(Fig. 5b) the decrease of the maximum of the curve of 4%! 3 was not 
significant. The pD2-va1ue of 5-HT was, however, significantly 
(p <0.05) reduced after the incubation with ACh with 0.45 log units. 
II 10 
Fig. 5b. Influence of incubation during 70 min with ACh (10-7M) 
on the response to 5-HT. ~ Log dose-response curve of 5-HT; 
o--o id., after incubation with ACh. ,_...., id., theoretical curve. 
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N 
00 
o------· --··~" ~---" 
Base- Antagonist Agonist % max .. pD2 line contraction 
= 
0 + 0 ACh 100 + 0 7.00 ±. 0.05 
-J + J 
Piperoxan ACh 99 ±. 2 6.80 + 0.10 (10-5M) 
J1 + 6 Ergotamine (to-8M) ACh 101 _+ 2 7.00 + 0.20 
12 + 4 Piperoxan + ACh 100 ±. J 6.70 + 0.15 Ergotamine 
6 id.' theor. ACh 100 6.80 
values 
0 ±. 0 5-HT 100 + 0 8.10 ±. 0.05 
0 + J Piperoxan 5-HT 101 + 1 6.90 ±. 0.10 (1o-5M) 
40 + 6 Ergotamine (to-8M) 5-HT Bo + 4 7.60 + 0.25 
26 + 6 Piperoxan + 5-HT 95 ± 5 6.55 + 0.15 Ergotamine 
22 id.' theor, 5-HT )80 6.40 
values 
Table 2. Inhibition by piperoxan of the ergotamine induced contraction 
left in contact with the tissue for 45 respectively 70 min and its 
influence on the effect of ergotamine on the response to ACh and 5-HT. 
All values are given.:!:_ S.E.M. and represent the mean out of 10 experiments. 
3.6. Influence of piperoxan on the effect of ergotamine on the response 
to ACh and 5-HT. 
In order to make the differentiation possible between the receptors for 
ergot-alkaloids and D-tryptamine receptors the influence of piperoxan, 
which is a benzodioxane, on the effect of ergotamine was investigated 
(Table 2). 
The response of the rat stomach strip to ergotamine (10-8M) left in 
contact with the tissue for 45 respectively 70 min were strongly inhibited 
piperoxan (10- 5M). The decrease of the pD 2-va1ue of ACh after piperoxan 
\'ias not significantly affected by ergotamine. With respect to the response 
to 5-HT the incubation with ergotamine resulted in a significant (p <0.05) 
further decrease of the pD 2-value of 5-HT after piperoxan with 0.35 log 
units. 
"· DISCUSSION 
Incubation of rat stomach strips with ergotamine resulted in a contract-
ion of the preparation. The magnitude of the submaxima 1 contractions 
induced by ergotamine gradually increased with time reaching their 
maximum value after 45-70 min. Similar to 5-HT (Gaddum, 1957; Offermeier 
and Arii!ns, 1966; '.Abramets, 1969; Dyer, 1974; Frankhuijzen and Bonta, 
l'S74a, b) the log dose-response curve of ergotamine was bell-shaped. 
1'iethysergide, used in a concentration of 10-8M and an incubation time 
of 20 min which was expected, according to its pDz-value (Frankhuijzen 
and Bonta, 1974b), to cause about 70% inhibition of the 5-HT induced 
contraction, nearly completely blocked the response to ergotamine. There-
fore a subsidiary action of ergotamine on a tryptamine receptor different 
from the cl ass1ca1 D-tryptamine receptor is excluded. For tryptamine it 
has been shown previously (Frankhuijzen and Bonta, 1974b) that the 
response mediated via this aberrant type of tryptamine receptor is very 
resistant to the inhibition by methysergide. The log dose-response curve 
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of 5-HT obtained after the incubation with ergotamine was not signi-
ficantly different from the theoretical curve in which the assumption 
was made of an interaction of both ergotamine and 5-HT with the same 
receptor. Moreover piperoxan (10-5M) which is shown to competitively 
antagonize the response to 5-HT {Frankhuijzen and Bonta, 1974b) 
inhibited the ergotamine induced contraction and affected the response 
to 5-HT in the presence of ergotamine in accordance with the supposition 
that all three drugs act on the same receptor. As pointed out above, 
the ergotamine-induced contraction of the rat stomach strip seems to be 
mediated solely by the classical a-tryptamine receptor. Several arguments 
can be found in the literature for the localization of the ·a-tryptamine 
receptors within the smooth muscle cell membrane (Born, 1962; Handschu-
macher and Vane, 1967; Born, 1970). The observed parallel shift to the 
left of the ergotamine log dose-response curve with increasing incubation 
times cannot for this reason be explained by an increased uptake of 
ergotamine into the smooth muscle ce11s. Several possible explanations 
can be given for the observed shift, all of which are based upon the 
assumption that the increase in the apparent affinity of rat stomach 
strips to ergotamine with time is caused by the low rate of increase of 
the contractile response. Possibly this is a reflection of a low rate 
of formation of the ergotamine/receptor-complex (Paton, 1961; Thron and 
Waud, 1968; Rang and Ritter, 1970; LUllmann and Ziegler, 1973) or of a 
low rate of the translocation of ca2+ across the cell membrane (Chang 
and Triggle, 1973). 
Influences not related to 5-HT or its receptors were not involved in the 
effects observed with ergotamine on the response to 5-HT. The log dose-
response curve of ACh obtained in the presence of ergotamine was nearly 
identical with the theoretical curve supposing an action of ergotamine 
and ACh on separate receptors. 
From the literature (Gaddum, 1957; Waud, 1968; Katz and Thesleff, 1957; 
Rang and Ritter, 1970; Pluchino, 1972; Chang and Triggle, 1973b) it is 
known that prolonged receptor stimulation might result in desensitization. 
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Nonspecific desensitization (Cantoni and Eastman, 1946) of the isolated 
rat stomach preparation after the prolonged stimulation of the D-
tryptamine receptors can be excluded because incubation with 5-HT 
affected the ACh log dose-response curve in a way similar to ergotamine, 
indicative for an action of 5-HT and ACh on different receptors. The 
5-HT curve was, however, shifted to the right resulting in a 4 fold 
decrease in apparent affinity. Direct extrapolation of the desensitizat-
ion induced by 5-HT to ergotamine is not allowed because of the uncertain-
ty whether or not partial agonists are able to induce desensitization 
(LU11mann and Ziegler, 1973; Chang and Triggle, 1973a, b). The contraction 
induced by ACh (10-7M) gradually decreased with time and caused a 
parallel shift to the right of both the ACh and 5-HT log dose-response 
. curve. The decrease of the contraction might have been caused by 
hydrolysis of the ACh, although the preparation was washed every 5 min 
after which ACh was administered again. Since the ACh log dose-response 
curve was shHted to the right after the incubation with ACh, tachy-
phylaxis seems to be a more appropriate explanation of the reduction of 
the response to ACh. Cholinergic mechanisms are supposed to be involved 
only in the action of 5-HT mediated by the neurotropic M-receptor 
(Gaddum and Picarelli, 1957; Gyermeck, 1966; Born, 1970). In literature 
however some support can be obtained for a cholinergic involvement also 
in the mediation of the action of 5-HT by D-tryptamine receptors 
(Leitch et a 1. , 1957). 
In conclusion the results of the experiments described clearly indicate 
a partial agonistic action of ergotamine on the D-tryptamine receptors 
of the isolated rat stomach preparation. In this respect no analogy 
exists, as with mianserin (Frankhuijzen and Bonta, 1974a; Saxena et al ., 
1971), with the results obtained by Saxena (1972) in which the selective 
vasoconstriction by-.ergotamine of the carotid vasculature seemed not to 
be mediated by 0-tryptamine receptors. 
Prolonged stimulation of the D-tryptamine receptors resulted in specific 
desensitization. Whether this phenomenon was also involved in the action 
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of ergotamine and to what extent remained uncertain. 
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ABSTRACT 
ROLE OF PROSTAGLANDINS IN TONE AND EFFECTOR REACTIVITY 
OF THE ISOLATED RAT STOMACH PREPARATION 
Abraham L. FRANKHUIJZEN and Ivan L. BONTA 
Dep!Xl'tment of Ph!Xl'macology, Medical Faculty, 
Erasmus UniVe1'BibJ 0 Rotterdam, The Netherlands 
The influence of indomethacin (2 ~g/ml) on the tone and the response to 
, 5-·HT and tryptam·l ne of the stomach strip preparation from norma 1 
and Essential Fatty Acid Deficient (EFAD) rats was examined. The pD 2 
value of ACh and 5-HT, but not of tryptamine, was significantly lower on 
the preparations obtained from EFAD rats than on those from normal rats. 
Contradictory results were obta·i ned with respect to the influence of 
indomethacin on the pD2 va 1 ue of ACh, 5-HT and tryptamine. No significant 
difference in initial tone and contractility of the stomach strips of 
both groups of rats was observed. However, the tone of the strips from 
normal rats increased 'with t·ime. Preparations from EFAD rats showed a 
gradua 1 decrease of the tone with time. Pre-incubation with indomethacin 
reduced the tone of strips from both groups of rats to a comparab 1 e 
extent. 
Thus further support is provided for the proposed role of prostaglandins 
in the maintenance of the tone of isolated smooth muscle. The possibility 
is raised that prostaglandins might not be predominantly invo1ved in the 
generat·ion of the initial tone and also not substantially contribute to 
the effector reactivity of the organ. 
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l, INTRODUCTION 
There now exists compelling evidence that the prostaglandins may well 
have a physiological role in modulating autonomic transmission. Prosta-
glandins are probably liberated at a large number of autonomic effector 
sites and they subsequently influence both the release of transmitter 
material and the reactivity of the effector organ to the transmitter 
{ . Hedqvist, 1973; Brody and Kadowitz, 1974). ACh (Ramwell et al., 
l966a; Coceani et ai., 1967; Coceani et al., 1968; Barles et al., 1968) 
as well as 5-HT (Ramwell et al., 1966b; Coceani et al., 1968; Alabaster 
and Bakhle, 1970; Holmes, 1970) and tryptamine (Alabaster and Bakhle, 
1970) increase the release of prostaglandins. This possibility implicates 
that prostag·landins are involved in the contractile responses to ACh, 
5-HT and tryptamine indirectly, if released in a subcontractile dose, by 
i nf1 uenci ng the reactivity of the effector organ and/ or directly if 
released in a contractile dose. 
We intended to investigate this possibility using the isolated rat 
stomach strip preparation (Vane, 1957), because of its high sensitivity 
towards 5-HT and prostaglandins. Furthermore, enzymes which synthetize 
prostaglandins have been isolated from homogenates of the rat stomach 
(Pace-Asciak et al., 1968; Pace-Asciak, 1972). 
Indomethacin, a compound which strongly inhibits prostaglandin bio-
synthesis (Vane, 1971), can be used to determine whether local generation 
of prostaglandins affected the contractile response to ACh, 5-HT or 
tryptamine. 
It has been shown that Essential Fatty Acid (EFA)-deficiency causes a 
pros tagl andi n deficiency (Van Dorp, 1971; Haddeman and Horns tra, persona 1 
communication; Tan and Privett, 1973). By using EFA-deficient (EFJ\.0) rats, 
effects simi 1 ar to the admi ni strati on of indomethacin on the tone and 
contracti1 e responses of the· preparations obtai ned from norma 1 rats , were 
to be expected. 
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2. MATERIALS AND flETHODS 
Male rats of an inbred strain of the Medical Faculty were used. Pregnant 
mothers of these rats were placed on an Essential Fatty Acid Deficient 
(EFAD) diet five days before the expected delivery. The EFAD food con-
tained 4% hydrogenated cocos fat while the control diet had 3.5% of its 
calories as linoleic acid. After weaning the newborn rats were kept on 
EFAD diet food. 
2, 'i. Prepa:t'ation of the stomach strip 
fn<C EFAD rats of 275-325 g and non-deficient controls of the same age of 
375-425 g were killed by decapitation. The stomach was dissected out and 
two strips of about 2 mm width were cut from the ruminal part of the 
stomach (Vane, 1957), whereby much care was taken not to introduce 
d-ifferences in the 1 ength of the strips. 
Threads were attached as close as possible to the ends of the strips. 
Strips were set up in an organ bath maintained at 37°C, containing Krebs 
solution and bubbled with a gas mixture containing 95% 02 - 5% co2. The 
composition of the Krebs solution was (mM): NaCl 118.0; KCl 4.7; 
CaC1 2 2.5; MgS04 1.17; NaH2Po4 1.17; NaHC0 3 25.0 and glucose 5.6. The 
length of the strips was determined by putting both ends of the strip 
together. The deflection recorded was divided by the magnification of 
the recording system, which consisted of a Harvard heart/smooth muscle 
transducer and a Harvard electronic recording module 350. 
2. 2. Experimental procedure 
Before starting the experiment the strips were allowed to equilibrate 
for 60 min during wh·ich the bathing fluid was changed every 15 min. For 
the experiments in which the contractile response of the preparation to 
PGE1 and PGF2a were compared with those of ACh and 5-HT a 25 min time 
schedule of drug administration was used as described previously 
(Frankhuijzen and Bonta, 1974). 
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In the experiments in which the influence of indomethacin on the tone 
and contractile response of the preparation was investigated, 4 strips 
were used at the same time: 2 strips (strip A1 and A2) were obtained from 
one stomach (A) of a rat kept on the control diet, the two other strips 
(strip B1 and B2) were obtained from one stomach (B) of an EFAD rat. 
Twenty min after indomethacin was administered to strips A2 and B2 all 
4 preparations were washed 3 times after which indomethacin \vas 
administered again. The strips were pre-incubated with indomethacin for 
120 min. Thereafter, the response to ACh or 5-HT was recorded and 25 min 
later the response to tryptamine. The length of the preparations was 
measured at the end of each experiment. 
For the statistical evaluation of the results these were tested two-sided 
at significance level 0.05. In the case of two independant samples (see 
3.1. and 3.2.) the Wilcoxon-Mann-Whitney U test was used. In the case of 
two related samples (see 3.3.) the Student's t-test was used. 
2. 3. Drugs 
The following drugs were used: acetylcholine iodide (ACh, Fluka A.G.), 
serotonin creatinine sulphate (5-HT, Fluka A.G.), tryptamine hydrochloride 
(Fluka A.G.), indomethacin hydrochloride (Indocid, Merck Sharpe and Dohme), 
prostaglandins E1 and F2a (PGE1 and PGF2a, Upjohn). The solutions were 
prepared freshly on the day of the experiment. Drug solutions were added 
to the 15 ml organ bath in a volume of 0.15 ml. All concentrations 
mentioned refer to the final concentration of the drugs in the organ bath 
and are, except for indomethacin, expressed in terms of molarity. 
3. RESULTS 
3.1. Response to PGE1 and PGF2a of the stomach strip obtained from normal 
rats: corrtpa:r>ison with the response to ACh and 5-HT. 
Cumulative dose-response curves of successively ACh, PGE1, 5-HT and PGF2a 
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were recorded using a 25 min time schedule. No significant difference in 
the slope of the log dose response curves was observed (Fig. 1). 
10 4 ~log ~one. 
Fig. 1. Log dose-response curves of 5-HT (x---x), PGE 1 ( 8---1 ), 
ACh (~) and PGF 2a. ( /';- /).) of stomach strips from normal rats. 
The curves represent the mean out of .20 experiments. The bars in 
the curves indicate the S.E.M. 
From table 1 it can be seen that the tone of the preparation gradually 
increased in time. The maximum of the PGF2 curve was 4% + 2 higher a -
(p <0.05) and of PGE1 4% ~ 2 lower (p <0.05) than the maximum of the 
5-HT curve, which on its turn was 5% ~ 2 lower (p <0.005) than the 
maximum of the ACh curve. No significant difference was observed between 
the maximal heights of the ACh and PGFza. curves. Rat stomach strips 
showed the highest affinity towards 5-HT followed by PGE1 and PGE2. The 
1 owes t affinity was observed for PGF Za., which was even 1 ower than for 
ACh. 
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' 
lll:\50-
% mnximl> l 
Agoniat contraclion pD2 (mln) line (r<'lativo 
'" ACh) 
0 0 ~ 0 ACh >DD 
" 
0 6.96 
" 
o.oB 
.:..5 
' " ' 
PGE 1 
,, 
" ' 
7.46 
" 
0.08 
50 6 
" ' 
5-HT 95 
" ' 
8.011 
" 
0.08 
75 5 
" ' 
PGF 2lx 99 .
' 
6.26 
" 
o. 10 
Splawin:>ky 
" 
ol. 
(197Jl PGE 2 95 7.36 
( 7- 51 
-
7-29) 
Table 1. Characteristics of the log dose-response curves of 
ACh, PGE,, 5-HT and PGF
2 
successively recorded with 25 min 
.c a 
interval in the order as given in the table~ The mean values 
obtained from 20 preparations are given ~ S.E.M. The values 
for PGE2 are also given and were derived from Splawinski et 
al. (1973). The pD 2 value of PGE 2 was corrected for the 
difference in sensitivity of the preparation as appeared from 
the comparison of the pD 2 value of PGF 2a given by Splawinsky 
et al. 
3.2. Influence of an EFAD diet on the response to ACh, 5-HT and 
tryptcorrine. 
Feeding of rats with an EFAD diet reduced the pD2 value of the stomach 
strips of ACh and 5-HT without significantly affecting the slope of the 
log dose-response curves (Fig. la, b). No significant change was observed 
with respect to the response to tryptamine (Fig. 2c). 
From the va 1 ues given in tab 1 e 2 it foll o~1s that the pD2 va 1 ue of ACh was 
reduced with 0.32 + 0.10 log units (p <0.05) and of 5-HT with 0.29 + 0.13 
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log units (p <0.05). The decrease of the pD 2 value of tryptamine was not 
significant (P >0.20). No significant difference was observed in the 
length of the preparations obtained from normal and EFAD rats, nor in 
the maximal response to ACh, 5-HT or tryptamine. 
"" 
I 
' ' 
4 -logiACh) 
11 10 5 -log (5-HT) 
I 
' ' 
2 -LogiT.-ypt.) 
Fig. 2. Log dose-response curves of ACh (a), 5-HT (b) and 
tryptamine (c) of stomach strips obtained from normal (o--o) and 
EFAD rats ( /':, --/SJ. Each curve represents the mean out of 20 
(ACh and 5-HT) or 40 (tryptamine) experiments. The bars in the 
curves indicate the S.E.M. 
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Length oC 
'"" 
% <nax~mal 
Agonist ,,, pr<•parat~on (mm) contraction 
' 
%C 
Normal rat~ ACh 7-09 
' 
o.o6 )0 
' 
' 
, 
' 
, 
HAD rat~ 
"" 
6.77 
' 
o.oB ,, 
' ' " ' ' 
/>.'ormal ,·.:;t~ 5-HT a.oit 
' 
o .o8 
" ' ' 
47 
' ' 
<.FAD rats 5-HT 7· 75 
' 
0.10 
'" ' ' 
46 
' ' 
Normal rats Trypt. 5· 40 
' 
0.09 
" ' 
' 
,,, 
' ' EFAO r"t.s Trypt. 5· 29 
' 
0.09 
" ' ' " ' 
J 
Table 2. Influence of EFA-deficiency on the tone and contractile 
response of rat stomach strips. The contractility of the preparations 
(%1) is expressed as the % maximal contraction induced by the agonist 
relative to the length (L) of the preparations. The values represent 
the mean + S.E.M. out of 20 (ACh and 5-HT) or 40 (tryptamine) 
experiments. 
3.3. Influence of indomethacin on the tone and the response to ACh, 5-HT 
and tryptamine of stomach strips from normal and EFAD rats. 
From table 3 it can be seen that the base-line of the preparations 
obtained from normal rats shifted upwards with time, indicating an in-
crease in tone (p <0.05- p <0.02). No significant difference was observed 
between the increase in tone after the administration of ACh, 5-HT or 
tryptamine. However, the tone of the preparations obtained from EFAD rats 
did not increase after ACh (p >0.5) or even decreased with time after 
5-HT (p <0.02) and tryptamine (p <0.05). Pre-incubation during 120-145 
min with indomethacin (2 ~g/m1) resulted in a decrease of the tone also 
of the preparations obtained from EFAD rats. Remarkable is that the base-
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1 i ne of the preparations from both norma 1 and EFAD rats in the presence 
of indomethacin descended to the same level (table 3). 
Strip 
A 1 , 2 { 20} 
At ( il>) 
Ac1 \ j(J) 
:I '~ ( ~·O j 
" 
liJI 
' 
" 
I i'•l 
'l '2( 20) 
A { i\)) 1 
,, ( 10) 
i::l1. 2 ( 20) 
\' ') 
82 ( 10) 
A l ' 2 { 40) 
At (.20) 
A2 (20) 
Ill '2 ( 40) 
u, (20) 
u2 (.20} 
' 
Base- Antagonist Agonist % maximal po2 pD 2 (t=150)-pV2 \t•O) (min) line contraction 
0 0 
-" 
0 ACh 100 
"-
0 7.09 ± o.o7 
150 8 
-" 
5 101 
"-
J 7.13 
-" 
0.08 0.04 
" 
0.06 {N.s. J 
150 -17 7 Indomctha- 101 2 6.92 0.04 -0.17 0.04 (P(0.005) 
" 
cin "-
" 
-" 
0 0 ± 0 EFAO ACh 100 "- 0 6.77 -" 0.09 
1';0 
-J ± J £FAD 102 "- 6.83 ± o.oa 0.06 
" 
0.06 (N. s.} 
150 - 1 (, ,, Indomctha- EFAD 101 
" 
cin 
" 
J 6.75 ± 0. 13 -0.02 
" 
0.07 (N .S.) 
0 0 ± 0 5-HT 100 "- 0 8.04 ± 0.11 
150 ,, 
-" 
,, 100 ± 2 8.12 
" 
0. 11 0,08 
" 
0.05 (P(0.20) 
150 _, G Indomc-tha- 102 
" 
2 7.96 
" 
0.15 -0.08 
" 
0.06 (P(0.20) 
.t cin 
0 0 
" 
0 £FAD 5-HT 100 
" 
0 ?.75 
" 
0. 14 
150 -9 
=- ' 
EFAD 100 
" 
2 B.o6 
" 
0. t/; 0.)1 
" 
0.08 (P(0.005) 
150 -11 
" 
7 Indometha- EFAD cin 102 "- 2 7-79 
" 
0.07 0.04 
" 
0.07 <~.s. J 
0 0 
" 
0 Trypt. ,, 
-" 
4 5.40 
"-
o.oB 
'" 
9 
" ' 
94 
-" 
J 5.46 
-" 
0.09 0.06 
"-
0.12 (N.S.) 
175 -23 
" 
5 
Indometha-
cin 89 -" 
2 5-39 
"-
o. 10 -0.01 ..t. 0. 13 <~.s. l 
0 0 
" 
0 EFAD Trypt. 98 =. 4 5.29 
" 
0.08 
175 -12 
" 
J EFAD >02 
-" 
5 5.)4 
" 
0.07 0.05 
"-
0. 11 (1'\ .s.) 
175 -24 
" 
5 Indomctha- EFAD 98 ..t. 
'"" 
4 4.89 
" 
0.10 -0.40 :!:.. 0. 1) (P( 0.005) 
Table 3. Influence of pre-incubation with indomethacin (2 ~g/ml) 
during 120 (ACh and 5-HT) or 145 min (tryptamine) on the tone and 
the characteristics of the log dose-response curves of ACh, 5-HT 
and tryptamine of stomach strips obtained from normal (A) and EFAD 
(B) rats. The values given in this table represent the mean + S.E.M. 
The number of experiments is given between parathesis. The changes 
of the initial pD 2 value of tryptamine with time is given after 
175 min pre-incubation. 
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Neither the maxima of the log dose-response curves recorded from the 
preparations obtained from normal rats nor those from EFAD rats changed 
significantly ·in the course of the experiments or were affected by the 
pre-incubation with indomethacin. 
t~ith respect to the pD2 values no such uniform effects were observed as 
v1ith the tone and maximal response (table 3). Together with the increase 
in tone of the preparations from normal rats the pD2 value of all three 
a~onists inc1'eased with time. However, this increase was statistically 
not s·ignificant. The increase 1vith time of the pD2 value of ACh and 
tl~yptamine of the preparations from EFAD rats was of the same magnitude 
as from norma.l rats but also not significant. The pD 2 value of 5-HT of 
strips from EFAD rats was however significantly (p <0.005) increased 
after 150 min. 
Pre-incubation of strips from both normal and EFAD rats with indomethacin 
generally decreased the pD 0 values of all three agonists if compared with 
'-
the blanks (table 3). With respect to the response to ACh of strips from 
normal and to tryptamine of EFAD rats the pD 2 value was significantly 
(p <0.005) decreased even below its initial value. 
4. DISCUSSION 
The tone of the stomach strip preparation obtained from normal rats 
gradually increased with time. A. similar increase of the tone with time 
was described for the isolated rabbit jejunum (Ferreira et al., 1972) 
and guinea-pig ileum (Botting and Salzmann, 1974). The finding that pre-
incubation with indomethacin (2 ]Jg/m1) during 2 hr gradually decreased 
the tone of the preparation confirmed the results obtained by Eckenfels 
and Vane (1972) on the same preparation and is in agreement with the 
results obtained by Farmer et al. (1972) and Botting and Salzmann (1974) 
on respectively the tracheal smooth muscle and isolated segments of the 
ileum of the guinea-pig and of Ferreira et al. (1972) on the isolated 
rabbit jejunum. Because of the correlation observed between the level 
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of prostaglandin release and the degree of inherent smooth muscle 
activity (Posner, 1970; Ferreira et al., 1972; Botting and Salzmann,1974; 
Vane and Williams, 1973) and the effect of prostaglandin antagonist 
(Bennet and Posner, 1971; Davison et al., 1972; Ganesan and Karim, 1973) 
it is generally accepted that the intramural generation of prostaglandins 
contribute in maintaining spontaneous activity of isolated smooth muscle 
tissue. 
The tone of the stomach strip preparation obtained from EFAD rats on the 
contrary gradually decreased with time. EFA-Defi ciency has been shown to 
be associated with prostaglandin deficiency as reflected in the difference 
between the PGE 2 content of tissues obtained from EFAD and normal animals 
(Van Dorp, 1971; Tan and Privett, 1973; Haddeman and Hornstra, personal 
communication). If this also holds for the ruminal part of the rat 
stomach then the decrease of the tone with time of the stomach strips 
from EFAD rats would provide further support for the involvement of 
prostaglandins in the maintenance of the tone. 
In line with this a lower initial tone of the stomach preparations 
obtained from EFAD rats as compared with those obtained from normal rats 
was to be expected. Under standardized conditions the strips should then 
show a difference in length. Indeed, the strips from EFAD rats were 1 mm 
longer than those from normal rats. This difference in length however, 
was statistically not significant (p >0.20). However, such a small 
difference in length, which is about 5% of the length of the preparation, 
might be too small to be accurately measured by the procedure used. Pre-
incubation during 2 hr with indomethacin (2 ~g/ml) gradually decreased 
the tone of stomach strips obtained from EFAD rats and normal rats to the 
same extent. According to reports in literature (Northover, 1971; 
Sorrentino et al., 1972; Farmer et al., 1972), it does not seem very 
likely that part of the loss of the tone was caused by a non-specific 
smooth muscle relaxation by indomethacin. Thus, it appears that 
prostaglandins are not predominantly involved in the generation of the 
initial tone of the preparation. However, the stomach strips from EFAD 
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rats were evidently still able to generate prostaglandins, although at 
a lower rate available. 
This might have been sufficient for the generation of the initial tone 
but not for the maintenance of the tone in time. Prostaglandin deficiency 
did not affect the contractility of the preparation. No significant 
difference was observed between the maximal responses to ACh, 5-HT and 
tryptamine of the preparations obtained from normal and EFAD rats. More-
over, pre-incubation with indomethacin of stomach strips obtained from 
either normal or EFAD rats did not affect the maximal response to ACh, 
5-HT and tryptamine. These results provide additional evidence against 
a non-specific smooth 
It is known that 5-HT 
.PJabaster and Bakhle, 
muscle relaxation by indomethacin. 
amwell et al., 1966b; Coceani et al., 1968; 
1970; Holmes, 1970), tryptamine (Alabaster and 
.Sakhle, 1970) as we11 as ACh (Ram1>~ell et al., 1g66a; Coceani et al. ,1967; 
Coceani et al ., 1968; Bartles et al., 1968) all increase the release of 
pi'OStaglandins. According to Coceani et al. (1968), 5-HT in a concen-
-5 tration of 5.10 M, increases the rate of prostaglandin release from the 
isolated rat stomach from 0.3 ng PGE 1 equiv./min till 2.5 ng PGE 1 
equiv./min. Extrapolating these data to the stomach strip and assuming 
a very rapid increase of the prostaglandin release, the administration of 
cumulative doses of 5-HT should have increased the prostaglandin level 
till a bath concentration equivalent to about 10-9M PGE1. According to 
the log dose-response curve of PGE 1, this still is a subcontractile 
concentration. 
Prostaglandins may influence the reactivity of the effector organ 
(c.f. Brody and Kadowitz, 1974) probably as the result of a general effect 
on membrane enzyme activities (Johnson and Ramwell, 1973; Coceani et al., 
1969) which will facilitate the translocation of membrane-bound ca2+ 
(Ca2+ ) (Coceani and Wolfe, 1966; Cocear.i et al., 1969; Horton, 1969; 
mem · 
Eagling et al., 1972; Kirtland and Baum, 1972; Carafoli and Crovetti, 
1973; Greenberg et al., 1973; Greenberg and Long, 1973). In the concept of 
Chang and Triggle (1973), the intrinsic activity is a reflection of the 
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ability of a drug to translocate ca2+mem Apparently, ACh, 5-HT and 
tryptamine, being full agonists, initiated a ca2+-translocation in such 
an effective manner that an additional facilitation by prostaglandins 
~~as without effect. 
The prostaglandins might however be involved effectively in the mediation 
of the response to submaximal concentrations of ACh and 5-HT. This is 
supported by the fact that the pD2 value of ACh and 5-HT of stomach strips 
obtained from normal rats was significantly higher than those obtained 
f~om EFAD rats. Moreover, the pD2 values were decreased after pre" 
incubation with indomethacin if compared with the blanks. However, the 
pD 2 values of ACh and 5-HT of stomach strips obtained from EFAD rats were 
also decreased after pre-incubation with indomethacin. 
In contrast with 5-i-H no si gni fi cant difference was observed between the 
pD 2 values of tryptamine of stomach strips obtained from normal and EFAD 
rats. This supports the suggestion that part of the response to tryptamine 
on the isolated rat stomach preparation is mediated via other than 0-
tryptamine receptors (Winter and Gessner, 1968; Frankhuijzen and Bonta, 
1974). Thus, obviously prostaglandins are not substantially involved in 
the subsidiary action of tryptamine. This conclusion is in agreement 
'01ith the finding that pre-incubation with indomethacin did not affect 
the pD2 value of tryptamine of strips obtained from normal rats. However, 
indomethacin significantly reduced the pD2 value of tryptamine of strips 
from EFAD rats. 
The present results provide additional evidence for the proposed role 
of prostaglandins in the maintenance of the tone of isolated smooth 
muscle. The possibility is put forward that prostaglandins are not 
predominantly involved in the generation of the initial tone. No definite 
answer can be given whether prostaglandins are involved in the mediation 
of the responses to ACh, 5-HT and tryptamine. The prostaglandins anyway 
did not substantially contribute to the mediation of the responses, 
although according to others (Sorrentino et al., 1972; Fried et al, 1969; 
Park et al., 1972; Sanner et al., 1973; Eakins et al., 1970) such a 
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contribution, although minimal, appears to be real. 
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SUMMARY AND CONCLUSIONS 
It has been shown that although the responses to 5-HT and tryptamine 
are affected by the same classes of antagonists, differences exist with 
fespect to the antagonism towards the action of tryptamine and 5-HT. The 
mary aim of this investigation was to ascertain whether the same types 
of receptors were involved in the action of these amines on the isolated 
rat stomach preparation. Since it has been demonstrated that both 5-HT 
and tryptamine are able to enhance the release of prostaglandins, the 
possibility of the involvement of prostaglandins in the contractile 
<'es ponses to 5-HT and tryptamine was a 1 so i nves ti gated. 
Mianserin and cyproheptadine are two structurally related antagonists of 
5-HT. However, in contrast to cyproheptadine, mianserin in concentrations 
up to 10-6M, failed to inhibit the 5-HT and tryptamine-induced contract-
ions of the isolated rat stomach preparation. By increasing the concen-
tration of mianserin the organ responded by contraction which was not 
affected by antagonists of ACh, histamine or 5-HT or by a- and s-adreno-
ceptor antagonists. These experiments were performed in the presence of 
the a-adrenolytic piperoxan to prevent the inhibitory action of 5-HT on 
a-adrenoceptors. Never the 1 ess, in receptor-protection experiments, both 
mianserin and piperoxan were able to prevent the inhibition of the 
contractile response to 5-HT by phenoxybenzamine. However, in separate 
experiments it could be demonstrated that both mianserin and piperoxan 
competitively antagonised the response to 5-HT. In view of the affinity 
of piperoxan to the 5-HT receptor, its interaction with other 5-HT 
antagonists was studied as well. From these experiments it was concluded 
that cyp·roheptadi ne as we 11 as methysergi de and ergotamine act as 
competitive antagonists to 5-HT and tryptamine on the isolated rat 
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stomach preparation. The 5-HT induced contractions were more affected 
than those induced by tryptamine. From thexe experiments it was concluded 
that the response to 5-HT was the result of an interaction with one type 
of receptor, probably the classical D-tryptamine receptor. The response 
to tryptamine seemed to be the result of an interaction with two 
different types of receptors. One type is identical with the receptor 
mediating the response to 5-HT, while the subsidiary action of tryptamine 
is mediated by another type of receptor which is more resistant to 
·JnhibHion. This type of receptor might be identical with the PRT 
(Phenoxybenzamine Resis1ant)-receptor, known to be more resistant to 
1 nhi bi ti on by phenoxybenzami ne. Moreover, in contrast with the 5-HT 
induced contraction, inhibition of the prostaglandin biosynthesis did 
not affect the tryptamine-induced contraction. In this way additional 
suoport was obtained for the suggestion of a divergence in the mediation 
the responses towards 5-HT and tryptamine. At the same time these 
experiments excluded the possibility of a substantial contribution of 
prostaglandins in the subsidiary action of tryptamine. Despite seeming 
analogy between the constrictor response of the external carotid vessels 
and the contractile response of the isolated rat stomach to ergotamine 
and mianserin, only for the contractile response to mianserin, receptors 
other than the classical D-tryptamine receptors appear to be involved. 
Prolonged receptor stimulation resulted in a specific desensitization. 
Since in the analysis of the effect of ergotamine on the response to 5-HT 
prolonged pre-incubation times were used, the possible involvement of 
receptor desensitization cannot be excluded. 
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SAMENVATTING EN CONCLUS!ES 
~,lhoewel er in kwalitatief opzicht overeenkomst bestaat tussen het 
antagonisme van de effecten van 5-HT en tryptamine, zijn er in 
kwan tati ef opzi cht verschi 11 en. Daarom werd met behul p van en ke 1 e 
5-HT anta.gonisten nagegaan of dezelfde typen receptoren betrokken 
riaren bij de door 5-HT en tryptamine gei'nduceerde contracties van 
strips van de rattemaag. Daar men heeft aangetoond dat zowel 5-HT als 
tryptamine in staat zijn de afgifte van prostaglandinen te verhogen, 
werd tevens onderzocht in hoeverre deze betrokken zijn bij de effekten 
van deze aminen. 
Mianserine en cyproheptadine zijn twee antagonisten van 5-HT, die wat 
betreft hun structuur sterke overeenkomsten vertonen. Toediening van 
mianserine (10-0M) gaf, in tegenstelling tot cyproheptadine, echter 
geen remming van de door 5-HT en tryptamine geinduceerde contractie 
van strips van de rattemaag. Verhoging van de concentratie van 
mianserine resulteerde in een contractie van het orgaan, die niet be-
invloed werd door anticholinergica, anti-histaminica, 5-HT-antagonisten 
of a- en B-adrenolytica. Teneinde de auto-inhibitie van 5-HT via a-
adrenerge receptoren te voorkomen werden deze experimenter. uitgevoerd 
in aanwezigheid van het a-adrenolyticum piperoxan. In receptor-
beschermingsexperimenten echter bleken zowel mianserine als piperoxan 
in s taat de remmi ng van 5-HT door phenoxybenzami ne te kunnen tegengaan. 
De conclusie dat mianserine en piperoxan blijkbaar affiniteit hebben 
voor de "5-HT receptor" werd nog eens bevestigd doordat beide afzonder-
lijk in staat waren de respons van 5-HT competitief te antagoneren. 
Derha1ve werd eveneens de invloed van piperoxan onderzocht op de 
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rel1lfling van de 5-HT en tryptamine contractie door cyproheptadine, 
methysergide en ergotamine. Uit deze experimenter. bleek dat zowel 
cyproheptadine als methysergide en ergotamine op competitieve wijze de 
5-HT en tryptamine effecten antagoneerden. De door 5-HT geinduceerde 
contractie werd echter sterker geantagoneerd dan die veroorzaakt door 
tryptamine. Deze resultaten toonden aan dat de 5-HT respons tot stand 
komt via een interactie met een type receptor. Deze receptOl' is waar-
schijn1ijk de klassieke 0-tryptamine receptor, terwijl het door 
tryptamine veroorzaakte effect vermoedelijk tot stand komt via een 
interactie met twee verschillende typen receptoren. Van deze twee 
receptoren is er een gelijk aan die waarmee 5-HT een interactie 
geeft. De tweede component van de tryptamine contractie verloopt via 
een ander type receptor, die mogelijk identiek is aan de PRT (Phenoxy-
benzami ne Res-isT ant) -receptor, v1aarvan bes chreven is, dat deze geen 
affiniteit voor phenoxybenzamine bezit. Bovendien bleek, dat de door 
tryptamine geinduceerde contractie, in tegenstelling tot die van 5-HT, 
niet beinvioed werd door remming van de biosynthese van prostaglandinen. 
Ook dit gegeven wijst op een verschillend mechanisme voor de door 5-HT 
en de door tryptamine geinduceerde contracties. Deze experimenten 
sluiten tevens de mogelijkheid uit dat prostaglandinen in belangrijke 
mate betrokken zijn bij de tweede component van de tryptamine respons. 
Geen overeenkomst bleek er te bestaan tussen de effecten van ergotamine 
en mianserine op het vaatbed van de carotis externa en op de strips 
van de rattemaag, met uitzondering van de door mi anserine veroorzaakte 
contractie die niet via de D-tryptamine receptoren tot stand leek te 
komen. Ergotamine bleek wel eer. partieel agonist te zijn op de D-
tryptamine receptor. Langdurige receptor stimulering had specifieke 
desensitizering tot gevolg. Daar bij de experimenter. met ergotamine 
langdurige pre-incubatie tijden werden gebruikt, bestaat de mogelijkheid 
dat ook hierbij receptor desensitizering is opgetreden. 
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